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Abstract 
 
Exercise is currently recommended for indivduals with type 1 diabetes since it is 
associated with physiological and psychological benefits (American Diabetes 
Association Position Statement, 2004; American College of Sports Medicine, 2010).  
However participation in exercise can increase the risk of experiencing hypoglyceamia, 
both during exercise and recovery (Rabasa-Lhoret et al., 2001).  Through discussions 
with practitioners that work with individuals that have type 1 diabetes, the development 
of clear evidence -based guidelines regarding adjustments in insulin doses and 
carbohydrate intake may  help prevent the risk of exercise induced hypoglyceamia.  
Specifically, there are limited evidence based guidelines for participation in intermittent 
high intensity exercise (IHE), which represents activity patterns of team and field based 
sports. Consequently, the aim of this thesis is to investigate the effects of a structured 
intervention for insulin and carbohydrate adjustment on blood glucose responses during 
and after IHE that replicates team and field based sports in individuals with type 1 
diabetes. 
 
Seven well-controlled participants with type 1 diabetes were tested on three separate 
occasions and interstitial glucose concentration was measured up to breakfast the 
following day on each occasion using a Continuous Glucose Monitor (CGM).  The first 
phase of this study compared a 30% post-exercise fast-acting analogue insulin reduction 
on the blood glucose responses to an afternoon bout of IHE (40 minutes of cycles of 
walking for 5 minutes at 40% OV
2 
max, jogging for 3 minutes at 70% OV
2 
max and 
sprinting for 5 seconds at 125% OV
2 
max) vs. continuous moderate intensity exercise 
(40 minutes at 50% OV
2 
max).  Results showed there was no significant difference 
between the CGM readings for moderate or IHE (p= 0.59) at any point during the 40 
minute exercise protocols and up to breakfast the following day.  There was a 
significant change in interstitial blood glucose concentration over time regardless of 
exercise condition (p< 0.001).  Regardless of exercise condition both moderate and IHE 
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is characterised by the risk of Late Onset Post-Exercise Hypoglycaemia (LOPEH).  In 
addition there appears to be a problem of hyperglycaemia, particularly two-four hours 
after the meal and insulin reduction.      
 
The second phase of the study compared the blood glucose responses to a 30% vs. a 
50% post-exercise fast-acting analogue insulin reduction after a bout of afternoon IHE 
in individuals with type 1 diabetes.  There was no significant difference in interstitial 
blood glucose responses as measured by CGM between the two insulin reductions and 
50% insulin reduction is no better for the prevention of LOPEH than the 30% reduction 
after IHE  (p= 0.06).  Blood glucose responses were similar for the same IHE on two 
separate occasions and there was a significant decrease in in interstitial blood glucose 
concentration as measured by CGM from 0-40 minutes of exercise (p= 0.002).  As 
observed in phase 1, the problem of hyperglycaemia was also evident.   
 
In conclusion, there are two main high-risk periods for the development of 
hypoglycaemia associated with IHE.  The first is immediately after exercise and the 
second later on during the night.  In addition hyperglycaemia seems to be a problem for 
up to four hours following the evening meal after exercise.  It is important to make 
patients aware of this, in order to prevent the long term complications associated with 
such.  Regardless, individuals vary in their responses to exercise and individual 
strategies to combat hypoglycaemia may be required.  A number of limitations are 
acknowledged within this study, however is they were eradicated, future research of this 
kind could have implications for the development of guidelines for the management of 
blood glucose concentration during and after IHE.   
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Chapter 1 
Introduction 
 
 
It is important for those with type 1 diabetes, especially young children and adults, to 
live a life as close to normal as possible (American Diabetes Association (ADA), 2004).  
This includes being physically active and having the option to participate in a range of 
sports and recreational activities.  Many individuals have been encouraged by examples 
of world class sportsmen with type 1 diabetes such as Sir Steve Redgrave and Gary Hall 
(Gallen, 2005).   
 
Physical activity is an important part of a healthy lifestyle.  Most recent government 
recommendations state that adults should accumulate at least 30 minutes of moderate 
intensity exercise at least five times a week (Department of Health, 2011).  The 
prescription of exercise for individuals with type 1 diabetes should be considered for its 
known benefits in controlling serum lipids, reducing blood pressure, improving insulin 
sensitivity, reducing weight and improving cardiovascular fitness (ADA Position 
Statement, 2004; American College of Sports Medicine (ASCM), 2010).  All of these 
benefits are likely to be significant for individuals with type 1 diabetes due to the 
increased risk of macro vascular disease within this population.  The ADA (2004) 
advocates that: 
 
“all levels of physical activity including leisure activities, recreational sports and 
competitive professional performance can be performed by those with type 1 diabetes 
who do not have complications and are in a state of good blood glucose control” (S61). 
 
One of the most popular forms of exercise, yet probably the most under-researched with 
respect to its responses in individuals with type 1 diabetes is known as Intermittent High 
Intensity Exercise (IHE).  This type of exercise is typical of many team and field-based 
sports such as hockey, basketball, football, rugby (Abdelkrim et al., 2007; Bloomfiled et 
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al., 2007; Lothian and Farrally, 1994; Spencer, 2005; Bailey et al., 1995), training 
regimes such as Fartlek or interval training, many gym classes and also spontaneous 
play in children.  IHE also accounts for much of the selection of sports played by 
children and adolescents (Raile et al., 1999).  The desire to participate in a team sport 
and become a team member is very often driven by social reasons and the need for those 
with type 1 diabetes to not appear different from their peers (Grimm, 2005).     
 
Unfortunately regular exercise for those individuals with type 1 diabetes does not 
necessarily lead to improved glycaemic control.  Through discussions with colleagues 
and health care professionals in the area of diabetes, the most important issue in those 
individuals with type 1 diabetes is understanding the impact that exercise has on blood 
glucose concentrations and developing knowledge and skills to avoid hypoglycaemia 
and hyperglycaemia. Therefore, those individuals with type 1 diabetes need to learn 
how to change their insulin administration and carbohydrate intake prior to, during and 
after exercise.  Research, however, would suggest that this is not any easy task since 
several factors such as duration and intensity of exercise; type and timing of insulin; site 
of injection and carbohydrate intake, can all influence the blood glucose response to 
exercise in individuals with type 1 diabetes (Toni et al., 2006).  All of the challenges of 
managing blood glucose concentrations whilst exercising contributes to the fact that less 
than 40% of people with diabetes are estimated to be physically active (Thomas et al., 
2004). 
 
   
It is apparent that there is a great need for the development of practical guidelines for 
controlling blood glucose concentrations in those with diabetes when undertaking 
exercise.  In particular there appears to be a need for information on IHE since it has 
been reported that individuals with type 1 diabetes may avoid team sports to prevent 
upsetting their peers in case of the possibility of a hypoglycaemic event or the 
inconvenience of regular blood glucose checks or carbohydrate snacking (Grimm, 
2005).  This study therefore came about from recognising the evidence gap and the 
dissatisfaction expressed by health care professionals about the inability to offer reliable 
advice in this area.  As a result, the primary goal of this research is to investigate the 
effects of an intervention for insulin and carbohydrate adjustment on blood glucose 
responses during and after IHE.  This should provide valuable information for health 
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care professionals who work with individuals with type 1 diabetes on how IHE may 
impact their condition and provide them with an understanding of the potential effect 
this type of training can have on blood glucose concentrations and the best ways to 
manage this.     
 
This chapter will outline the background in relation to type 1 diabetes and exercise, 
including demonstrating the need for a greater understanding of the management 
strategies required for individuals with type 1 diabetes to take part in IHE.  The focus of 
the research is identified and justified and the overall research aims and individual 
research objectives are identified.   
 
1.1 Type 1 Diabetes 
 
Type 1 diabetes, known as insulin dependent diabetes mellitus accounts for 10-15% of 
all cases of diabetes and affects around 16 million individuals worldwide (Guelfi et al., 
2007b).  In 2010 Diabetes UK indicated that there were 27, 367 patients with type 1 
diabetes in Scotland.  This contributes to Scotland having the third highest incidence 
rate of type 1 diabetes in the world, behind Finland and Sardinia (The Scottish 
Government, 2010).  Type 1 diabetes can develop at any age however it accounts for 
over 90% of diabetes in those aged 25 and under in Scotland (SIGN, 2010). 
 
Type 1 diabetes is an autoimmune disease that results from beta-cell destruction of the 
pancreas, resulting in an inability to produce insulin, a key hormone in the regulation of 
blood glucose (Grimm, 2005).  In non-diabetic individuals the level of circulating 
insulin is directly controlled by the concentration of glucose in the blood that passes 
through the beta cells of the pancreas (Henquin, 2000).  As the concentration of glucose 
in the blood rises so do insulin levels, thus lowering the blood glucose concentration.  In 
reverse, a decrease in blood glucose concentration inhibits the secretion of insulin.  In 
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this manner insulin increases or decreases the production and utilisation of glucose as 
necessary in order to maintain euglycaemia.
1
 
 
In contrast, in the absence of circulating insulin, those with type 1 diabetes will 
experience a build-up of glucose in the bloodstream.  This is as a result of lack of both 
inhibition of hepatic glucose production and stimulation of peripheral glucose uptake 
(Rizza et al., 1981).  Further increases in blood glucose occur in the presence of high 
levels of counterregulatory hormones including glucagon, growth hormone, cortisol, 
norepinephrine and epinephrine which all oppose the action of insulin (Pierce, 1999).  
High levels of counterregulatory hormones combined with insulin deficiency exaggerate 
the increase in blood glucose concentration (Pierce, 1999; Riddell and Perkins, 2006; 
Toni et al., 2006). 
 
Individuals with type 1 diabetes face the daily challenge of maintaining their blood 
glucose within the normal physiological range (4-8 mmol.l
-1
) through self-
administration of exogenous insulin, regular glucose monitoring and careful control of 
their diet (Guelfi et al., 2007b).  Maintaining blood glucose within the normal 
physiological range is not an easy task for individuals with type 1 diabetes, with 
consequent problems of excessive or insufficient insulin administration.  Too much 
insulin in relation to carbohydrate intake can cause blood glucose concentration to 
decline below 4 mmol.l
-1
 and result in symptoms of hypoglycaemia.  These symptoms 
can be mild, such as loss of coordination, mental confusion, sweating, tremors and 
hunger, and can be easily recognised by the patient and reversed with a small amount of 
carbohydrate.  It may, however, be severe enough to cause unconsciousness requiring 
an injection of glucagon.  In rare circumstances it may cause brain damage or even 
death (Cryer, 2003).  According to the Diabetes Control and Complications Trial (1993) 
hypoglycaemia is the most frequent, acute and adverse complication of type 1 diabetes. 
  
While too much insulin in relation to carbohydrate intake can cause hypoglycaemia, a 
                                                          
1
 Key Definition: Euglycaemia is the normal concentration of blood glucose in the blood (4-8mmol.l
-1
).  
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relative deficiency in insulin dosage in relation to carbohydrate intake can result in 
hyperglycaemia (blood glucose > 10 mmol.l
-1
).  Whilst these conditions may reduce the 
risk of hypoglycaemia, hyperglycaemia can lead to thirst, fatigue, blurred vision, 
drowsiness, abdominal pain and nausea (Farrell, 2003).  Perhaps of more importance, 
chronic hyperglycaemia over several years can lead to disturbances in metabolism and 
long term organ damage such as diabetic retinopathy, neuropathy and cardiovascular 
disease (Pierce, 1999).    
 
1.2 Exercise and the Risk of Hypoglycaemia in Individuals with Type 1 
Diabetes 
 
Although all the aforementioned long-term benefits of exercise for individuals with type 
1 diabetes are well known, perhaps of more importance to those with type 1 diabetes is 
the acute metabolic costs of taking part in exercise. The most frequent and dangerous 
consequence of exercise in individuals with type 1 diabetes is hypoglycaemia during 
and up to 12-31 hours after exercise (Rabasa-Lhoretet al., 2001).  Hypoglycaemic 
symptoms during exercise are also often difficult to detect as many of the symptoms are 
common to the exercising individual such as sweating and tachycardia (Grimm, 2005).  
As a result of the risk of exercise-induced hypoglycaemia, health care professionals 
have attempted to offer advice to prevent blood glucose concentrations falling too low 
during and up to 31 hours after exercise.  This would seem important since it has been 
reported that the biggest barrier to participating in regular exercise in adults with type 1 
diabetes is the fear of hypoglycaemia (Brazeau et al., 2008).   
 
Although exercise-induced hypoglycaemia is a legitimate fear, the ADA (2003) state 
that it is possible to safely enjoy the benefits of exercise by balancing exogenous insulin 
administration and carbohydrate intake.  However, effective adjustment of these 
parameters would require an understanding of the metabolic and hormonal responses to 
exercise.  Several factors such as duration and intensity of exercise, type and timing of 
insulin, site of injection and carbohydrate intake, can all influence the blood glucose 
response to exercise in individuals with type 1 diabetes (Toni et al., 2006).  
Consequently much research has focused on examining the glucoregulatory responses 
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to different types of exercise in order to develop evidence based guidelines for adjusting 
carbohydrate intake and insulin doses for safe participation in physical activity.   
 
1.2.1 Moderate Intensity Exercise 
 
Moderate intensity exercise involves continuous aerobic activity between 40-59% 2OV
  
max
2
 or 55-69% of maximum heart rate (HR) (ADA Position Statement, 2004).  
Examples of this type of exercise are continuous aerobic activities such as cycling, 
swimming and jogging.  It is well established that participation in moderate intensity 
exercise typically lowers the blood glucose concentration and increases the risk of 
hypoglycaemia during exercise and recovery (Francescato et al., 2004).  The natural 
decline of serum insulin that occurs during moderate intensity exercise in a healthy 
individual cannot occur in individuals with type 1 diabetes.  In contrast, insulin 
concentrations could rise if the injected insulin has been administered into exercising 
muscle (Pierce, 1999).  As a result hepatic glucose production does not increase 
adequately to cope with fuel requirements, provoking hypoglycaemia to occur.  
Furthermore there is a relatively higher insulin concentration in the periphery during 
exercise which promotes peripheral muscle glucose uptake, and this again predisposes 
the individual to hypoglycaemia (Lumb and Gallen, 2009a).  Evidence suggests that the 
risk of hypoglycaemia during moderate intensity activities can be minimised by 
appropriately reducing the pre-exercise bolus insulin dose and/or ingesting additional 
carbohydrates (West et al., 2010; Lumb and Gallen, 2009a&b; Perry and Gallen, 2009; 
Robertson et al., 2008; Kordi and Rabbani, 2007; Riddell and Perkins, 2006; Toni et al., 
2006; Grimm et al., 2004; Rabasa-Lhoret et al., 2001; Pierce, 1999).  The risk of 
hypoglycaemia can extend for up to 31 hours after exercise (MacDonald, 1987).  This is 
as a result of increased insulin sensitivity and an increase glucose uptake for 
replenishment of muscle and liver glycogen stores.  Hypoglycaemia that occurs more 
than four hours after exercise has been classed as late-onset post-exercise 
hypoglycaemia (LOPEH).  This can be a considerable issue as LOPEH is often 
associated with sleep, meaning that the hypoglycaemic episode is less likely to be 
recognised.  Strategies to combat LOPEH include reducing insulin dosage prior to 
                                                          
2
 Key Definition: 2OV
  max is the maximum rate an individual can take up and utilise oxygen during 
incremental exercise and reflects the physical fitness of an individual.      
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bedtime following late afternoon exercise and/or increasing carbohydrate intake 
(MacDonald, 1987).       
 
1.2.2 High Intensity Exercise  
 
High intensity exercise is classified as activity at or above 80% 2OV
 max or 75% of HR 
maximum or above (Grimm, 2005).  This type of exercise includes sprint activities and 
can-not be maintained for a long period of time since it relies predominately on 
anaerobic metabolism.  During high intensity exercise in individuals with type 1 
diabetes there is a progressive rise in blood glucose concentration due to an exercise-
induced increase in hepatic glucose production that exceeds glucose uptake.  This has 
been attributed to the rise in catecholamines in response to exercise (Riddell and 
Perkins, 2006).  During recovery there is an absence in endogenous insulin secretion in 
response to high concentrations of blood glucose, resulting in prolonged 
hyperglycaemia.  It is therefore recommended that a smaller additional dose of insulin is 
encouraged if hyperglycaemia is a frequent problem after high intensity exercise 
(Marliss, 2002).         
 
1.2.3 Intermittent High Intensity Exercise 
 
Although the responses to moderate and high intensity exercise are well established, the 
response to a combination of these two types of exercise, a form of physical activity 
known as intermittent high intensity exercise (IHE) has received little attention in the 
literature.  In the current research IHE will be defined as exercise that involves short 
repeated bouts of intense activity, interspersed with longer periods of moderate intensity 
activity or rest (Guelfi et al., 2005a).    The high intensity periods of exercise associated 
with IHE in field and team-based sports last between 2-3 seconds in duration and 
require considerable amounts of energy via anaerobic sources such as Adenosine 
Triphosphate (ATP), Creatine Phospahte (CP) and muscle glycogen stores (Spencer et 
al., 2005).  The lower intensity periods of exercise in IHE offer a period of recovery for 
resynthesis of ATP, CP and glycogen stores and removal of lactate.  During IHE in 
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individuals with type 1 diabetes it has been reported that glucose concentrations fall less 
rapidly during exercise than with moderate intensity exercise and also remain stable 
during the hour after exercise, even when the total amount of work done in IHE is 
greater (Guelfi et al., 2005b). 
 
1.3 Research Focus 
 
The lack of research into the blood glucose responses to IHE is reflected in existing 
guidelines which do not distinguish between continuous and intermittent exercise.  At 
present recommendations are not evidence-based and advice suggests similar 
management strategies for blood glucose concentrations during and after IHE as for 
moderate or high intensity exercise alone (Birrer and Sedaghat, 2003; Grimm et al., 
2004; Pierce, 1999).  Often guidelines suggest the importance of patients monitoring 
their own blood glucose response to exercise and using this to improve glycaemic 
control the next time the same exercise is performed (ADA Position Statement, 2004).  
It has further been suggested that the management of blood glucose concentrations is 
more difficult during IHE in comparison to continuous moderate or high intensity 
activities alone (Guelfi et al., 2007).  It is therefore important to appreciate that there 
may be differences in the metabolic responses to IHE compared with other forms of 
exercise and as a result different management strategies may be required for individuals 
with type 1 diabetes. 
 
Despite recent studies attempting to address the glucoregulatory responses to IHE in 
type 1 diabetes (Iscoe and Riddell, 2011; Maran et al., 2010; Guelfi et al., 2005a; Guelfi 
et al., 2005b), there are still no evidence-based recommendations for insulin and 
carbohydrate adjustments during this form of exercise for individuals with type 1 
diabetes.  It may be advantageous for health care professionals and those that work with 
individuals with type 1 diabetes to have information on how IHE may impact their 
condition and have an understanding of the potential effect this type of training can have 
on their blood glucose and the best ways to manage this.   
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1.4 Aims and Research Objectives 
 
The overall aim of this research is to investigate the effects of a structured intervention 
for insulin and carbohydrate adjustment on blood glucose responses during and after 
IHE that replicates team and field based sports in individuals with type 1 diabetes.  This 
should further add to current research on IHE and will contribute to the body of 
evidence required to develop appropriate insulin dose and carbohydrate 
supplementation for those with type 1 diabetes, to allow for safe participation in 
intermittent activities.   
 
Specifically the individual research objectives are to: 
1. Identify and critically appraise current evidence detailing the impact of IHE on 
blood glucose concentrations in individuals with type 1 diabetes.  
2. Compare the effects of a 30% post-exercise fast acting analogue insulin 
reduction on the blood glucose responses to a bout of IHE vs. continuous 
moderate intensity exercise in individuals with type 1 diabetes.  
3. Compare the blood glucose responses to a 30% vs. a 50% post-exercise fast 
acting analogue insulin reduction after a bout of IHE in individuals with type 1 
diabetes.  
 
Objective one will be met by the means of a literature review, objectives two and three 
through empirical data collection and analysis.  
 
1.5 Structure of Thesis  
 
This thesis is organised as a series of chapters: 
 
Chapter 1: Introduction 
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This chapter has provided a background on exercise and type 1 diabetes, including 
illustrating the importance of the understanding of blood glucose control during and 
after exercise.  The focus of the research is identified and the aims and research 
objectives are highlighted.  
 
Chapter 2: Intermittent High Intensity Exercise and Type 1 Diabetes: A Review of 
the Literature Carried out in a Systematic Way. 
This chapter critically appraises the current evidence base on IHE and exercise in type 1 
diabetes.  Current guidelines for the management of type 1 diabetes in relation to IHE 
are also reviewed.  
 
Chapter 3A: Development of the Intervention and the Intermittent High Intensity 
Exercise Protocol  
This chapter discusses and describes the intervention for insulin and carbohydrate 
adjustment and also the IHE protocol that was designed for use within this study. 
 
Chapter 3B: Methodology 
This chapter provides details and justification of the research methods used for 
empirical data collection in this study.  Details of the sample selection, data collection 
and data analysis methods are also outlined.   
 
Chapter 4: Results 
This chapter describes the outcomes of the empirical data collection and provides a 
description of the results concentrated around research objectives two and three.   
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Chapter 5: Discussion 
This chapter describes, discusses, analyses and synthesises the empirical findings 
concentrated around research objectives two and three.  Results are also compared and 
contrasted with findings from the literature review in Chapter 2.   
 
Chapter 6: Conclusions 
This chapter will revisit the overall aim and specific research objectives of this study.  
The findings are summarised and conclusions from this research are derived.  
Limitations of this research are also highlighted, along with directions for future 
research.   
 
The following chapter - Intermittent high intensity exercise and type 1 diabetes: A 
review of the literature carried out in a systematic way - examines the literature in 
relation to IHE and type 1 diabetes. 
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Chapter 2 
Intermittent High Intensity Exercise 
and Type 1 Diabetes: A Review of the 
Literature 
 
As discussed previously it is important for individuals with type 1 diabetes to be 
physically active and participate in a range of sports and recreational activities.  It is 
well established within the research that continuous moderate and high-intensity 
exercise have a contrasting effect on blood glucose concentrations and risk of 
hypoglycaemia, therefore they require different management strategies to maintain 
euglycaemia.  What remains unclear is the responses to a form of activity known as 
IHE.  Given that there is an increased demand for evidence-based guidance on the 
management of type 1 diabetes for IHE, this chapter will review the literature on IHE 
and type 1 diabetes in a systematic way.  The focus of this literature review will be 
based upon the overall study aim detailed in the introductory chapter.  This overall aim 
of this research is to : 
 
“investigate the effectiveness of a structured intervention for insulin and carbohydrate 
adjustment on blood glucose responses during and after Intermittent High Intensity 
Exercise (IHE) that replicates team and field based sports in individuals with type 1 
diabetes.” 
 
Therefore the aim of this literature review is to identify and critically appraise current 
evidence detailing the impact of IHE on blood glucose in type 1 diabetes, thus 
addressing objective 1 outlined in sub-section 1.3 in Chapter 1.  In addition any current 
guidelines for managing insulin adjustment and carbohydrate intake for participation in 
IHE for those with type 1 diabetes will also be reviewed.  
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2.1 Methods 
 
A systematic approach was undertaken in order to identify relevant literature and to 
assess the quality of each research article.   In contrast to narrative reviews which are 
often very subjective, have no defined method and are therefore very difficult to 
replicate (Hek and Langton, 2000), systematic reviews use explicit rigorous methods for 
searching, critiquing and synthesising the literature (Averyard, 2010).  The rationale for 
the use of a systematic approach to searching for and reviewing the literature was the 
need to identify empirical findings, appraise all quality research and identify any gaps in 
the literature regarding blood glucose responses to IHE in type 1 diabetes.  A systematic 
approach also means that the review process is replicable, updateable and should limit 
bias (Mulrow, 1994).  This should allow accurate conclusions to be drawn about the 
direction of the evidence regarding IHE in type 1 diabetes. This literature review was 
conducted following general principles from the SIGN (2001) and the Cochrane 
Collaboration (2006).  A systematic approach was taken at each stage in the literature 
review process: searching the literature based on key words, identifying literature, 
implementing the inclusion/exclusion criteria on the literature, critiquing and 
synthesising the literature.   
 
2.1.1 Search Strategy 
 
The following data-bases were used for the search: MEDLINE, BNI, SPORTDiscus, 
CINAHL and The Cochrane Library (1980-2011). Key words were identified as Type 1 
Diabetes, Blood Glucose, Intermittent Exercise/Intermittent High Intensity 
Exercise/Team Sports, Insulin Adjustment and Carbohydrate Administration.  The 
search strategy included Medical Subject Headings (MeSH) and terms were truncated 
with (*) to allow for multiple spellings, endings and common words related to the key 
terms.  In addition the BOOLEAN operators AND and OR were used.  The search terms 
insulin adjustment, carbohydrate administration and self-management did not find any 
publications.  It was therefore thought that under the term Type 1 Diabetes more related 
articles would be found.   The search strategy employed in the databases relating to this 
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review is highlighted in Figure 2.1.  Individual search information for each database can 
be found in Appendix 1.  The last search was carried out on 28/06/2012.  
 
In addition a hand search of the reference lists of relevant literature was conducted to 
identify all eligible reports or trials not included in the electronic search.  A search of 
grey literature, Google Scholar, SIGN:http://www.sign.ac.uk, NICE:  
http://www.nice.org.uk/Guidance/Topic, National Library of Guidelines: 
http://www.library.nhs.uk/guidelinesFinder/ and Edinburgh Napier University Library 
Catalogue was also undertaken (1980-2012).  A further three articles were found that 
did not appear in the database search that were deemed relevant.   
 
Initially articles deemed appropriate were identified through examination of abstracts.  
After the initial literature search it became apparent that due to the lack of randomised 
control trials (RCTs) assessing the research question any published literature that was 
relevant would be considered.  Foreign articles were not included.  It became evident 
that there was no published literature that specifically addressed or tested any insulin 
and carbohydrate adjustment for individuals with type 1 diabetes wishing to take part in 
IHE.  Several studies were found within the literature search that made reference to IHE 
and provided some guidance on this issue.  A summary of the advice given within these 
studies will be included within this review.       
  
2.1.2 Inclusion/Exclusion Criteria for Randomised Control Trials 
 
The following inclusion criteria was applied for any RCT’s that were to be included in 
this review: (1) published in the English language, (2) participants must be adult 
humans over the age of 18, (3) participants must have Type 1 Diabetes, (4) IHE must be 
used as the primary intervention, (5) the target clinical outcome must be blood glucose, 
(6) literature from 1980 onwards.  A broad time frame has been selected since it became 
apparent that there was a relatively small amount of literature available.  
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2.1.3 Statistics  
A meta-analysis has not been conducted mainly due to the heterogeneity of the studies, 
particularly regarding the methodological differences in exercise protocols and work to 
recovery ratios used within the RCTs.   
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Figure 2.1. Search Procedure and Results from the Databases.         
Type 1 Diabetes 
(MH "Diabetes Mellitus, Type 
1") OR "type 1 diabetes" , DE 
"DIABETES" OR DE 
"DIABETIC athletes" OR DE 
"INSULIN resistance", (MH 
"Diabetes Mellitus, Insulin-
Dependent") 
(n = 20,462) 
 
 
Intermittent High Intensity 
Exercise 
intermittentexercis*, 
intermittent high intensity 
exercis*, team* and sport* 
(n = 135, 658) 
 
Blood Glucose 
(MH "Blood Glucose") OR "blood 
glucose" OR (MH "Blood Glucose 
Self-Monitoring"), DE "BLOOD 
sugar" OR DE 
"HYPOGLYCEMIA" OR DE 
"HYPERGLYCEMIA" OR DE 
"GLUCOSE" 
(n = 161,098) 
Combined Using AND 
(n = 45) 
Included 
(n =13 ) 
6 = Randomised Control 
Trials 
7 = Review Articles (3 
from Grey Literature) 
 
 
Excluded 
(n = 32 ) 
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2.2 Results 
 
The literature search highlighted a total of 45 articles.  These articles were initially 
screened for suitability of inclusion.  Of these 45 articles 32 were excluded since they 
did not meet the specified inclusion criteria.  Some of the studies were conducted in 
children under the age of 18, one study was a training study and blood glucose was not 
a clinical outcome, participants from another study were individuals with type 2 
diabetes and another study was a Cochrane review in pregnant women with Type 1 
Diabetes.  Of the 13 studies that were included seven were review articles and six were 
RCTs.  Sample size in the studies range from six-11 participants.  Table 2.1 displays a 
summary of the included RCT studies that address the research aim.  Table 2.2 outlines 
the review articles from the literature search that mentioned IHE and summarises the 
advice given to individuals with type 1 diabetes.     
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Table 2.1. Summary of Randomised Control Trials Included in the Review. 
Author Participants Methods IHE Protocol Adjustments to 
Insulin and 
CHO Advice 
Blood Glucose 
Outcome 
Measures 
Results Key Messages 
Iscoe 
and 
Riddell 
(2011) 
 
11 trained 
athletes T1D (6 
female, 5 
male), age 35.1 
± 3.5 years 
(6 subjects on a 
pump) 
 
45 mins cycling 
MOD (55% 
WRpeak) v IHE 
 
45 mins cycling 
@ 50% 
WRpeak with 9 
15s sprints 5 
mins apart at 
100% WRpeak 
 
Standard meal 
given prior to 
exercise and 30g 
CHO given at 
bedtime 
following 
exercise 
Capillary 
glucose taken 
during exercise. 
CGM worn 72h 
before and up to 
16h after 
exercise. 
 
No difference in BG 
between trials. IHE is 
associated with less 
post exercise 
hypoglyceamia and 
more post exercise 
hyperglycemia 
(p<0.05)  
 
Moderate exercise 
combined with IHE 
protects against 
nocturnal 
hypoglycaemia 
compared to 
moderate exercise 
alone 
 
Maran 
et al 
(2010) 
 
 
 
8 Male T1D, 
Physically 
Active, Age 34 
± 7 years 
30 mins cycling 
MOD (40% OV
2
max  ) v IHE 
30 mins Cycling 
@ 40% OV
2
max  
interspersed 
with 5s sprints 
@ 85% OV
2
max  every 2 
mins 
Reduce evening 
dose of fast 
acting insulin by 
20% at following 
evening meal 
Blood sampled 
during ex @ 15, 
30 mins and up 
to 150 mins 
after ex. CGM 
worn for up to 
20h after 
exercise 
BG ↓ during both ex 
protocols. 
150 mins after ex 
plasma BG higher in 
IHE (not significant). 
Number of hypos 
after IHE greater 
than MOD (p< 0.05). 
IHE is associated 
with nocturnal 
hypoglycaemia 
compared to MOD 
ex. CGMs is a useful 
approach for those 
with T1D who 
exercise. 
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Guelfi 
et al 
(2007a) 
 
 
 
 
9 (5 male, 4 
female) T1D 
Physically 
Active, Age 
22.6 ± 5.7 
years 
30 mins cycling 
MOD (40% 
OV
2
 peak) v 
IHE  
All done under 
euglycemic 
clamp conditions 
with infusion of 
glucose 
30 mins cycling 
@ 40% OV
2
peak 
interspersed 
with 4s sprints 
every 2 
minutes.  
 
Insulin Infusion  Blood sampled 
every 5 mins 
during ex and 
for up to 2h 
after recovery 
During IHE glucose 
Ra increased earlier 
and glucose Rd 
increased sooner 
compared to MOD. 
Lower glucose 
infusion rate during 
early recovery in IHE 
(p< 0.05). 
Lesser decline in 
glycaemia with IHE 
due to greater 
increase in glucose 
Ra during exercise 
and attenuated Rd 
during exercise and 
early recovery. 
 
 
Guelfi 
et al 
(2005a) 
 
 
 
8 T1D, Age 
18.6 ± 2.1 
years 
 
 
IHE (cycling) v 
Control (seated 
with no exercise 
for 20 mins) 
 
 
Cycling for 20 
mins with 
eleven 4s 
sprints repeated 
every 2 mins 
 
 
Participants 
instructed to use 
usual insulin 
regime  
 
 
Capillary and 
venous blood 
sampled during 
exercise and for 
1h after 
 
 
During first 15 mins 
ex BG ↓ in IHE 
compared to Control 
(p< 0.05). 
During recovery BG 
was stable in IHE but 
↓ in Control (p< 
0.05). 
 
 
IHE does not increase 
the risk of early post 
exercise 
hypoglycaemia in 
those with T1D.  
 
Guelfi 
et al 
(2005b) 
 
7 (4 male, 3 
female) T1D, 
Age 21.6 ± 4.0 
years 
 
30 mins cycling 
MOD (40% 
OV
2
 peak) v 
IHE 
 
Cycling @ 40% 
OV
2
peak with 
4s sprints every 
2 mins 
 
No adjustments 
to participants 
usual insulin and 
CHO doses were 
applied 
 
Capillary blood 
was sampled 
every 10 mins 
during exercise 
and every 15 
mins after up to 
1h after 
exercise 
 
Both protocols 
resulted in a ↓ of BG, 
decline was greater 
in MOD (p< 0.05).  
During recovery BG 
remained higher in 
IHE but continued to 
↓ in MOD (p< 0.05). 
 
The decline in BG is 
less with IHE than 
MOD during exercise 
and recovery in those 
with T1D. 
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Ford et 
al 
(1999)  
6 (2 males, 4 
females), Age 
19-52 years, 
Physically 
Active 
30 mins 
treadmill 
running at 40%  
OV
2
max v 
four 2 min walk 
or runs at 
velocity at VT, 
with 2 min 
walks @ 
80m.min
-1 
Treadmill: Six 
20s  sprints at 
120% OV
2
max  with 2 
min walk 
recovery at 54 
m.min
-1
 
Participants told 
to manipulate 
insulin dose 
prior to own 
exercise 
Capillary BG 
assessed pre 
and post ex 
(immediate and 
20 mins 
following 
IHE produces a 
significantly higher 
BG than walking (p< 
0.01) and VT (p< 
0.05). 
BG values across 
time did not 
significantly change 
during any ex 
protocol 
IHE at 120% OV
2
max  tends to 
moderately ↑ BG in 
those with T1D. 
 
 
(BG: Blood Glucose, T1D: Type 1 Diabetes, Ex: Exercise, RCT: Randomised Control Trial, MOD: Moderate Exercise, IHE: Intermittent High 
Intensity Exercise, Mins: Minutes, s: seconds, Rd: Rate of Disappearance, Ra: Rate of Appearance, ↓: Decrease, ↑: Increase, VT: Ventilatory 
Threshold, CHO: Carbohydrate). 
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Table 2.2. Current Guidelines for Managing Intermittent High Intensity Exercise for 
Individuals with Type 1 Diabetes.   
Author Type of Exercise Advice for Insulin 
and Carbohydrate 
Adjustment 
Tested in 
Practice/Evidence 
Based Practice 
Lumb and Gallen 
(2009) 
IHE eg. Football Basal dose 
adjustments may be 
required.  
No 
 
Perry and Gallen 
(2009) 
 
IHE 
 
Smaller reductions in 
insulin dose and CHO 
supplementation than 
MOD intensity 
exercise to prevent 
hypoglycaemia  
 
No 
 
Guelfi et al (2007b) 
 
IHE: team sports 
 
None given as states 
not enough 
information on the 
glucoregulatory 
responses to this type 
of exercise 
 
No 
 
Toni et al (2006) 
 
IHE: Team Sports 
 
Reduce pre-meal 
insulin by 70-90%. 
May not be necessary 
to reduce pre-meal 
insulin if game is < 60 
mins. 
Reduce overnight 
basal insulin by 10-
30%. 
 
No 
 
Grimm et al (2004) 
 
Cycling, jogging, 
tennis, football, 
basketball (20-60 
mins) 
 
<60% max HR: 15g 
CHO; 60-70% max 
HR: 30g CHO; >75% 
max HR 75g CHO, 
insulin dosage ↓ 0-
20% 
 
Yes 
 
Birrer and Sedaghat 
(2003) 
 
“vigorous competitive 
activities”: swimming, 
cycling, basketball, 
soccer 
 
25% reduction in 
insulin dose and 15-
30g of rapid absorbing 
CHO prior to and at 
30 minute intervals if 
exercise duration is < 
1h. 
 
No 
 
Pierce (1999) 
 
Rugby, football, 
hockey, marathons, 
triathlons 
 
70-90% reduction in 
insulin dose before 
exercise  
 
No 
    
 
(CHO: Carbohydrate, MOD: Moderate Intensity Exercise, IHE: Intermittent High 
Intensity Exercise, max HR: Maximum Heart Rate, ↓: Decrease). 
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2.3 Discussion 
 
Despite the glucoregulatory responses to moderate and high intensity exercise being 
well established within the literature, the glucoregulatory responses to IHE has received 
very little research attention in the past and no direct guidelines are available for insulin 
and carbohydrate adjustment prior to or after this form of exercise.  The lack of research 
in this area is limiting since IHE is typical of activity patterns in many team and field 
sports such as rugby, hockey and football and is also typical of many forms of interval 
training.  This literature review addressed research objective 1 outlined in section 1.3 in 
the introduction chapter.  The aim was to identify and critically appraise current 
evidence detailing the impact of IHE on blood glucose concentrations in individuals 
with type 1 diabetes. 
 
Study findings from the RCTs in this current review are inconclusive regarding the 
effects of IHE on blood glucose concentration in individuals with type 1 diabetes.  
Results from one RCT indicate that IHE can moderately increase blood glucose 
concentration during exercise (Ford et al., 1999).  In contrast other studies have found 
that the short-term decline in blood glucose concentration is lower with IHE compared 
with moderate exercise of the same duration during both exercise and recovery of up to 
an hour after exercise (Maran et al., 2010; Guelfi et al 2005a; Guelfi et al 2005b).  It 
has also been found that compared with moderate intensity exercise, IHE results in a 
similar decline in blood glucose concentration during exercise but IHE is associated 
with less post-exercise hypoglycaemia (Iscoe and Riddell, 2011).  Interestingly a lesser 
decline in glycaemia with IHE may be attributed to a greater increment in glucose rate 
of disappearance during exercise and early recovery (Guelfi et al., 2007a).  Additionally 
it was demonstrated that nocturnal hypoglycaemia is detected in response to IHE 
performed in the afternoon, a previously unrecognised phenomenon (Maran et al., 2010; 
Iscoe and Riddell, 2011).   
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2.3.1 Factors that Influence the Blood Glucose Response to Exercise 
 
In order to critically appraise each RCT and understand the blood glucose responses to 
IHE it is important to identify and discuss key factors responsible for the blood glucose 
responses to any form of exercise.  These factors have been highlighted by the ADA 
(2008) who state that the glycaemic response to exercise in individuals with type 1 
diabetes can be variable and are dependent on: 
 
 Duration, intensity, type and timing of exercise  
 Type and timing of insulin and carbohydrate intake 
 Circulating insulin concentration 
 Blood glucose concentration before the start of exercise 
 Overall metabolic control (expressed as HbA1c) 
 Exercise experience of the subjects 
 
The following sections will discuss these key factors that are responsible for the blood 
glucose response to exercise and how these relate specifically to IHE and the RCT 
studies highlighted within this literature review.  In addition the limitations of these 
studies will be discussed throughout.   
 
2.3.1.1  Duration, Intensity, Type and Timing of Exercise 
 
The difficulty in conducting research into the blood glucose responses to IHE could be 
due to the fact that intermittent exercise can encompass a wide range of exercise 
protocols with varying work to recovery ratios.  The heterogeneity of the IHE protocols 
used within the RCTs in this study could impact upon study findings.  Ford et al (1999) 
examined the response of blood glucose concentrations to six repeated bouts of 20 
second efforts at 120% OV
2
max, performed every two minutes with an active walking 
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recovery (54 m/min
-1
) in between.  This study was one of the only studies along with 
Maran et al (2010) and Iscoe and Riddell (2011) to quantify the intensity of the sprint 
component.  The walking component used as the recovery period was the same intensity 
for every participant meaning that training status of the participants was not taken into 
account (Ford et al., 1999).   A further limitation of the protocol used in Ford et al’s 
study (1999) was that the work to recovery ratio used does not accurately reflect the 
intermittent nature of most team sports in which the high intensity intervals are much 
shorter in duration than the 20 seconds used.  Studies that have published time motion 
analysis during competition, in general have reported that the mean duration for high 
intensity sprints in sports such as football, hockey and rugby is 2-3 seconds (Duthie et 
al., 2005; Spencer et al., 2004; Mohr et al., 2003; Bangsbo et al., 1999).  
 
In contrast to Ford et al (1999) the remaining RCTs in the review used similar IHE 
protocols (Iscoe and Riddell, 2001; Maran et al., 2010; Guelfi et al., 2007a; Guelfi et 
al., 2005a; Guelfi et al., 2005b).  The first study examined the effects of repeated bouts 
of high intensity exercise on blood glucose concentration compared with remaining 
inactive (Guelfi et al., 2005a).  The IHE consisted of a 20 minute cycling protocol with 
four second sprints performed with two minutes of passive recovery between the 
sprints.  Although the work to recovery ratios used in this study were based on time 
motion analysis of team and field sports (Spencer et al., 2005), the recovery between the 
bouts was passive.  In the field intense bursts of high intensity activity are often 
interspersed with periods of lower intensity activity.   
 
This issue was addressed in subsequent studies where the IHE protocol was 30 minutes 
in duration with four second high intensity sprints interspersed with 2 minutes of 
moderate intensity exercise at 40% OV
2
 peak (Guelfi et al., 2005b; Guelfi et al., 
2007a).  Maran et al (2010) also used a similar protocol working at 40% OV
2
max for 
30 minutes with a five second sprint interspersed every two minutes.  Iscoe and 
Riddell’s (2001) IHE protocol consisted of working at 50% Work Rate peak for 45 
minutes with nine 15 second bouts at 100% Work Rate peak interspersed every five 
minutes.     
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In all the RCTs where a similar IHE protocol was implemented the decline in blood 
glucose concentration was less during IHE in comparison to moderate intensity exercise 
(Maran et al., 2010; Guelfi et al., 2007a; Guelfi et al., 2005a; Guelfi et al., 2005b).  In 
slight contrast it was also found that interstitial blood glucose declined similarly in 
moderate intensity exercise and IHE exercise trials (Iscoe and Riddell, 2011).  The one 
study that used a different IHE protocol with different work to rest ratios detected a 
slight increase in blood glucose concentration (Ford et al., 1999).  This indicates that 
different work to rest ratios used in IHE protocols might alter the blood glucose 
response.  This may have practical implications for athletes in the field where it is 
impossible to precisely reflect the complex activity and recovery patterns (or different 
positional demands) common to many team sports.  Furthermore the generalisation of 
these findings within this review to all team sports is limited since most team sports last 
up to 80-90 minutes, yet the reviewed studies used 20-30 minutes of exercise.  
 
It is also important to note that the variation in the number of sprints performed 
throughout the protocol, although similar across all the reviewed studies, may also 
significantly alter the relative energy system contribution and the metabolic demand of 
exercise thus potentially affecting the blood glucose response.  This issue is one that 
needs to be addressed in further studies.      
 
In addition to the duration, intensity and timing of exercise protocols performed, the 
exercise mode may also impact upon the blood glucose response to exercise.  Within the 
existing literature all the included studies with the exception of one, who use a treadmill 
protocol (Ford et al., 1999), perform cycling exercise.  This is an oversight since in 
almost all team based sports the mode of exercise is walking/running/jogging. The lack 
of research using the exercise mode that is specific to IHE is limiting since it has been 
found that eccentric muscle actions, such as those that occur during running or walking, 
can slow down insulin action and glucose uptake for up to 48 hours after exercise in 
comparison to concentric muscle actions which are typical of cycling exercise (Asp et 
al., 1996).  This implies that the blood glucose responses could be different depending 
on whether cycling or running exercise is performed.  Results from the RCT studies in 
this review where cycling was used as a mode of exercise (Iscoe and Riddel, 2011; 
Maran et al., 2010; Guelfi et al., 2007a; Guelfi et al., 2005a &b; Ford et al., 1999) 
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should be considered with caution when applying the results to team based sports in the 
field.  In order for the findings to be truly applicable to team sports, future studies 
should investigate the blood glucose responses to IHE using a mode of exercise that is 
sports specific.  
 
2.3.1.2  Type and Timing of Insulin and Carbohydrate Intake  
 
It is also possible that a different glycaemic response may be observed during exercise 
performed at varied time intervals following different energy intake and insulin 
administration. The included studies have employed real life protocols to examine the 
responses to exercise.  Two studies have commenced in the morning with participants 
injecting their normal insulin dose prior to consuming a standardised breakfast and 
following three and a half hours after breakfast the exercise sessions took place (Guelfi 
et al., 2005a; Guelfi et al., 2005b).  Other morning exercise designs include an 
overnight fast with the commencement of exercise before the participant administers 
their insulin dose and consumes breakfast (Guelfi et al., 2007a).  In contrast Maran et al 
(2010) investigated afternoon exercise followed by advice to reduce the evening dose of 
fast-acting insulin by 20%, and Iscoe and Riddell (2011) in their study, had their 
participants perform afternoon exercise following a standardised lunch five hours 
before, followed by 30g of carbohydrate at bed time.  Finally Ford et al (1999) looked 
at afternoon exercise one hour after lunch.  Participants in this study were allowed to 
determine the best regime for them in terms of insulin and food intake.   
 
The time of the day in which exercise was performed may influence the blood glucose 
response to the bout of exercise performed since the bodies need for insulin is lower at 
certain times within the day.  The risk of hypoglycaemia is less for exercise performed 
in the morning than in the afternoon since circulating insulin levels are lower and 
muscle glycogen stores are full (Toni et al., 2006).  There could thus potentially be a 
risk for nocturnal hypoglycaemia to occur in individuals who take part in 
afternoon/evening exercise.  This risk could be heightened if participating in IHE since 
there is a greater utilisation of muscle glycogen in this type of exercise (Guelfi et al., 
2007a).  Maran et al (2010) proved that the risk of nocturnal hypoglycaemia was greater 
after IHE through the use of a CGM which showed that glucose concentrations between 
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00:00 and 06:00am were significantly lower (p< 0.05) than after moderate intensity 
activity (number of hypoglycaemic attacks was 7 and 2 in IHE and moderate trials 
respectively).  Unfortunately participation in any exercise generally increases the risk of 
hypoglycaemia and blood glucose concentration showed to decrease generally across 
the board in all studies after the exercise trials.  Each study reported hypoglycaemia 
occurred whether the sessions took place in the morning or afternoon.     
  
In addition it may be important to consider the timing of exercise after insulin injection.  
Leaving an interval of two-three hours between the last meal/insulin injection avoids 
exercising during peak insulin action where the risk of hypoglycaemia is high (Grimm, 
2005).  Two studies left an interval of three and a half hours (Guelfi et al., 2005; Guelfi 
et al., 2005b) after injection before exercise however one study commenced exercise 
within an hour (Ford et al., 1999) and one omitted any information about timing of 
exercise and insulin injection (Maran et al., 2010).    
 
While the real life protocols employed in the formerly discussed studies offer an 
advantage of providing an element of reality by stimulating normal conditions by which 
exercise may be commenced in individuals with type 1 diabetes, they sacrifice 
experimental control in doing so.  This is particularly true of Ford et al’s (1999) study 
with blood glucose being difficult to match between experimental trials.  One further 
limitation of the “real life” protocols is that it is difficult to match blood glucose 
concentrations at a similar time from insulin injection between different trials.  In order 
to overcome this limitation some studies have used a protocol to clamp blood glucose at 
a constant level by infusing glucose or insulin.  In this review one study utilised a 
euglycaemic clamp protocol where blood glucose was maintained at 5.5 mmol.l
-1
 for the 
duration of the exercise trials by infusing 20% of dextrose solution at a variable rate 
(Guelfi et al., 2007a).  Although they may be able to keep blood glucose concentration 
at a constant this clamp protocol would have been invasive and expensive.  Furthermore 
results may not be applicable compared to those other studies using “real life” protocols 
since blood glucose does not remain constant in real life.            
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The difference in experimental design in relation to insulin protocols may in part 
explain some differences in the results.  In contrast to Guelfi et al (2005b), Guelfi et al 
(2007a) found that after two hours of recovery the decline in blood glucose 
concentration for IHE may not be less than moderate intensity exercise.  Participants in 
Guelfi et al (2007a) were fasted overnight but in a post-prandial state in the previous 
study (Guelfi et al 2005b).  Lower pre-exercise hepatic glycogen concentration resulting 
from fasting may have impaired the exercise induced rise in glucose production.  The 
levels of circulating insulin was also marginally higher in one study (Guelfi et al., 
2007a) which may have slowed the exercise induced increase in glucose production 
while enhancing glucose uptake.  In complete contrast Ford et al (1999) found that 
blood glucose concentration marginally rose after IHE.  There was however a lack of 
control over eating and insulin regimes in this study which may or may not have 
impacted upon the blood glucose concentration.   
 
2.3.1.3  Circulating Insulin and Blood Glucose Concentration Before 
Exercise 
 
The amount of circulating insulin and the blood glucose concentration before exercise is 
also critical to exercise performance and a major determinant to the glycaemic 
responses to exercise (Wasserman and Zinman, 1994).  A major problem for individuals 
with type 1 diabetes is that plasma insulin concentration does not decrease during 
exercise as it would normally do.  Conversely it may increase due to increased insulin 
sensitivity, enhanced absorption and if exercise is commenced shortly after insulin 
injection (especially with rapid analogues) (Robertson et al., 2008).  It is therefore of 
paramount importance that prior to and during exercise a certain concentration of 
circulating insulin should be maintained to prevent over-insulinization (causing blood 
glucose concentration to decrease) and under-insulinization (causing blood glucose 
concentrations to increase).  Perry and Gallen (2009) have recommended that ideally 
exercise should commence with a blood glucose concentration of 7-12 mmol.l
-1
.  Only 
two studies made reference to blood glucose concentration prior to exercise and both 
stated that participants blood glucose concentration should be 11 mmol.l
-1
 (Guelfi et al., 
2005a; Guelfi et al., 2005b).   
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Although no study made reference to the site of insulin injection it is worth noting that 
this can also influence the rate of insulin absorption and thus the response to exercise 
(Kovisto and Felig, 1978).  Individuals should avoid administrating insulin in body 
parts that will be involved in exercise.  This will make it easier to anticipate the blood 
glucose responses to insulin and aids with the management of exercise (Toni et al., 
2006).  Care must also be taken to avoid intramuscular injections which can cause 
hypoglycaemia particularly if followed by exercise (Perry and Gallen, 2009).   
 
2.3.1.4  Metabolic Control and Fitness Level of Participants 
 
The overall metabolic control and fitness level of the participants have been identified 
as factors that can influence the blood glucose response to any bout of exercise (ADA, 
2008).   All participants used within the included RCTs were in good metabolic control 
prior to participation as reported by mean Haemoglobin A1c   (HbA1c ) levels (%): 7.0 ± 
0.4 (Guelfi et al., 2005a), 7.4 ± 1.5 (Guelfi et al., 2005b), 7.7 ± 0.8 (Guelfi et al., 2007) 
and 7.14 ± 0.6 (Maran et al., 2010).  Ford et al (1999) however failed to report  HbA1c 
levels.  This is an important omission as HbA1c is used as an index of long term blood 
glucose control, ie blood glucose concentration that existed for the previous 2-3 months.  
According to the National Institute of Health (2010) an individual with good control 
over their diabetes will have an HbA1c level of 7% or less.  Results of the Diabetes 
Control and Complications Trial show that near-normal and normal HbA1c levels (< 
6.5-7%) limit the progression of long term complications from diabetes (Diabetes 
Control and Complications Trial Research Group, 1993).  Without information on 
HbA1c levels it is difficult to tell if the participants used in the Ford et al (1999) study 
had good glycaemic control. 
 
It is possible that the fitness level or exercise experience of the participants may also 
play a role in determining the blood glucose response to IHE.  Participants used in 
Maran et al (2010), Guelfi et al (2007a) and Ford et al (1999) were all physically active.  
The remaining studies made no reference to the exercise experience of their participants 
(Guelfi et al., 2005a; Guelfi et al., 2005b).  All of the studies however performed 
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exercise at a percentage of the participants OV
2
 max, in order to account for differing 
fitness levels of the participants.  This is particularly important since research has 
shown that compared with untrained, physically active individuals utilise less 
carbohydrates and more free fatty acids, even when working at a relative intensity 
(Francescato et al., 2005).  This would result in a slower decline in muscle and liver 
glycogen stores for those individuals who are physically active.  Exercise performed on 
a regular basis may also increase insulin sensitivity (Steppel and Horton, 2003), which 
could theoretically increase the risk of hypoglycaemia. 
 
2.3.2 Current Guidelines for Individuals with Type 1 Diabetes Participating in 
IHE 
 
The lack of research into the blood glucose responses that reflect the intermittent nature 
of team sports has not prevented the publication of recommendations for adjusting 
insulin and carbohydrate doses for this type of exercise.  These recommendations can be 
seen in Table 2.2 and have been summarised to demonstrate the current guidelines for 
managing the risk of hypoglycaemia associated with IHE for individuals with type 1 
diabetes.    
 
An issue with many of these recommendations is that they do not attempt to 
differentiate between continuous moderate intensity exercise and IHE and many suggest 
similar management strategies for both types of activity (Grimm et al., 2004; Birrer and 
Sedaghat, 2003; Pierce, 1999).  Guidelines by Grimm et al (2004) classify the exercise 
intensity based on HR and recommend a similar amount of supplemental carbohydrate 
and reduction in insulin dose for continuous activities such as cycling and jogging to 
that of intermittent sports such as tennis, football and basketball that result in an 
equivalent heart rate.  The basis of this recommendation was that a greater reduction in 
insulin and increased carbohydrate supplementation would be required for higher 
intensity exercise compared to moderate intensity exercise of the same duration.   
 
Pierce (1999) suggests that the management of blood glucose concentrations for 
vigorous team sports such as rugby and football should be similar to that of prolonged 
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exercise such as marathons where there should be a 70-90% reduction in insulin dose.  
Similarly Birrer and Sedaghat (2003) have recommended the same management for 
intermittent activities such as football and basketball to continuous activities such as 
cycling and swimming.   
 
While some recommendations do not distinguish between continuous and intermittent 
activities, other research scarcely mentions advice for IHE and simply makes one or two 
brief statements while going into great detail regarding advice for moderate intensity 
activity (Lumb and Gallen, 2009; Perry and Gallen, 2009).  The advice given to those 
with type 1 diabetes wishing to participate in IHE seems to be difficult to interpret and 
this issue is exaggerated by one study addressed within this review that looks at the 
responses to intermittent exercise and claim their findings to be applicable to 
intermittent sports such as hockey, basketball and football (Ford et al., 1999).  This is 
despite the fact that the exercise protocol used does not accurately reflect the work to 
recovery ratios observed in intermittent sports.   Despite a number of recommendations 
being made regarding the best way for individuals with type 1 diabetes to manage IHE 
very few of these have been tested in practice therefore advice should be taken with 
caution.    
 
2.4 Implications, Practical Applications and Directions for Future Research 
 
The literature reviewed here may have implications for the practical application for 
developing further studies that investigate the effects of IHE on blood glucose 
concentrations in individuals with type 1 diabetes, in particular the development of this 
present research.     
 
An important aspect of previous research that should be considered is the limited time 
frame of examination for the potential development of hypoglycaemia after exercise.  
Conclusions from the included studies were based on monitoring the subjects using 
standard self-blood glucose monitoring (SBGM) for as little as 20 minutes after exercise 
(Ford et al., 1999) and up to 150 minutes after exercise (Maran et al., 2010).  These 
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limited observation periods are too short to draw any firm conclusions on the role of 
IHE on post exercise hypoglycaemia.  Low blood glucose concentrations which can 
lead to LOPEH may occur up to 31 hours after exercise (MacDonald, 1987).  LOPEH is 
often nocturnal for those who exercise in the afternoon, meaning that the 
hypoglycaemic episode is less likely to be detected and has been suggested to disturb 
sleep patterns, alter recovery and therefore affect physical performance the following 
day (Pierce, 1999).     
 
Isoce and Riddell (2011) and Maran et al (2010), however additionally used a 
Continuous Glucose Monitoring Device (CGM) and monitored glucose concentrations 
for 20 hours after the cessation of exercise.  One study demonstrated that IHE is 
associated with a greater risk of nocturnal hypoglycaemia compared to moderate 
intensity exercise (Maran et al., 2010).  This is a clinically important observation 
particularly as the fear of post-exercise hypoglycaemia discourages those with type 1 
diabetes to take part in exercise (Grimm, 2005).  This may also be clinically important 
since some research is recommending that IHE may be preferential over moderate 
intensity activity or high intensity activity for complication free individuals with type 1 
diabetes (Guelfi et al., 2007b).  This recommendation is based on study results that 
show that the decline in blood glucose concentration is less for IHE compared with 
moderate exercise since the risk of a hypoglycaemia is theoretically less likely (Guelfi 
et al., 2005b).  However this was only based on monitoring blood glucose for 60 
minutes after the exercise protocols.   These new findings by Maran et al (2010) 
therefore do not support Guelfis’ (2007b) existing recommendations.  However Iscoe 
and Riddell (2011) found that IHE is not associated with the risk of LOPEH.  Due to 
results being conflicting there is the need for further studies that increase the 
observation window following the cessation of exercise and utilise a CGM to allow for 
a more precise understanding of the daily glucose fluctuations, particularly during the 
night after a bout of exercise, are required to characterize the impact of IHE on LOPEH.  
 
Findings from this review also do not support present advice given for insulin and 
carbohydrate adjustment for individuals with type 1 diabetes participating in IHE.  In 
contrast to studies that suggest similar management strategies for IHE as moderate 
intensity activities (Birrer and Sedaghat, 2003; Grimm, 2004; Pierce, 1999), the 
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reductions in insulin dosage required may be less for IHE due to the higher intensity 
nature of the exercise.  This has been suggested by Perry and Gallen (2009) but has 
never been tested in practice.  Additionally the suggestion that short repeated bouts of 
high intensity activity in IHE will have the same effect on blood glucose concentration 
as high intensity exercise alone (Mitchell et al., 1998), is also inappropriate given that 
there is involvement of moderate intensity activity interspersed between the high 
intensity component of IHE.   Guidelines that suggest similar management strategies for 
continuous exercise that result in similar heart rate responses to IHE are also not 
supported.  In the comparison of moderate and IHE the decline in blood glucose 
concentration is less for IHE despite this exercise eliciting a higher heart rate response 
(~85% and ~67% of age predicted HR maximum in IHE and moderate protocols 
respectively) (Guelfi et al., 2005).  HR values in the upper aerobic threshold (70% of 
maximal HR and above) result in higher rates of glucose oxidation (Perry and Gallen, 
2009) and this therefore suggests a greater risk of hypoglycaemia.   
 
Despite the lack of clear guidelines available in the literature for health care 
professionals IHE could confer added physiological benefits over moderate intensity 
exercise due to the overall higher intensity nature of the exercise.  This greater intensity, 
if regularly performed would likely result in improvements in aerobic capacity, weight 
control and also blood lipid (ADA, 2008).   
 
It is important to note that many of the reviewed studies have very small sample sizes.  
Clearly the nature of the interventions presents challenges to recruitment of patients and 
that the small sample size is the most prevalent methodological flaw in these studies.  In 
addition in order for the above mentioned findings to be truly applicable to individuals 
with type 1 diabetes wanting to participate in IHE there is a need to better reflect the 
complex nature of team and field based sports.  This includes using work to recovery 
ratios and modes of exercise that are sport specific to IHE.  In addition there is a need 
for guidelines for insulin and carbohydrate adjustments during and after IHE that have 
been tested in practice.  If IHE stimulates LOPEH (Maran et al., 2010) then a further 
decrease in the basal insulin dose after exercise (more than 20%) may be required.   
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2.5 Conclusions 
 
There remains a gap in evidence to advise health care professionals and individuals with 
type 1 diabetes wishing to take part in IHE.  The studies highlighted in this review have 
reported potential effects that IHE may have on the blood glucose response in 
individuals with type 1 diabetes.  The protocols within the reviewed studies differ 
slightly therefore it is difficult to predict with certainty the effects of blood glucose on 
IHE.     
 
However as mentioned previously it is important to appreciate that the management of 
exercise and type 1 diabetes requires careful consideration of the complex interaction 
between multiple factors.  These multiple factors are likely to influence the blood 
glucose response to IHE.  Crucially in order to provide clear guidelines for the 
management of IHE for individuals with type 1 diabetes research needs to distinguish 
between moderate intensity and IHE and not treat each exercise intensity as alike.  In 
order to develop a greater understanding of the blood glucose responses to IHE and the 
best ways to manage this, additional studies are required. 
 
This literature review has thus formed the basis for empirical data collection in this 
study.  This study will enhance the research discussed within this review in the 
following ways: 
 
 This study will attempt to differentiate between moderate and IHE.  Much of the 
advice in the literature for individuals wanting to take part in IHE is often 
conflicting and suggest similar management strategies for both moderate 
intensity and IHE (Birrer and Sedaghat, 2003; Pierce, 1999).  
 
 Most other studies investigating IHE in individuals with type 1 diabetes have 
been conducted in the morning (Guelfi et al., 2007; Guelfi et al., 2005a&b; Ford 
et al., 1999).  The rationale for having participants exercise in the afternoon was 
that through patient discussions many take part in exercise in the afternoon 
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following work.  In addition, lunch is often consumed around 12-1pm which is 
around three-four hours prior to exercise.  Participants were instructed to inject 
their lunch insulin dose at least three hours before exercise so that minimal bolus 
insulin was still active at the time of exercise.  The purpose of this was to 
prevent individuals exercising at a high-risk time for developing hypoglycaemia, 
considering that peak fast acting insulin action is around 40-90 minutes 
(Robertson et al., 2008; Noble et al., 1998).  Results of this study are likely to be 
transferable to a real life situation of exercise in the afternoon.   
 
 In addition many of the studies as discussed do not accurately reflect the true 
nature of IHE and utilise exercise modes and work to recovery ratios that are not 
representative of IHE (Iscoe and Riddell, 2001; Maran et al., 2010; Guelfi et al., 
2007; Guelfi et al., 2005a&b; Ford et al., 1999).  This study will thus attempt to 
utilise a novel IHE protocol that accurately reflects the intermittent nature of 
team and field based sports (Spencer et al., 2005).  
 
 
 Due to many results being conflicting there seems to be a need for further 
studies that will increase the observation window of blood glucose responses 
following the cessation of exercise.  Maran et al (2010) and Iscoe and Riddell 
(2011) used a CGM in order to do this.  In order to further understand the 
glucose fluctuations, particularly over-night after exercise, this research will also 
utilise a CGM and monitor interstitial blood glucose up to breakfast the 
following day.   
 
 Finally, the research in this review has highlighted the need for some clear and 
practical guidelines for insulin and CHO adjustments both during and after 
exercise.  This research will thus utilise a novel intervention for insulin and 
carbohydrate adjustment that will be used for exercise performed three hours 
after a fast-acting analogue dose.  While the outcome of this study will not allow 
for clear guidelines to be developed, this study could be a starting point for 
providing some important information to health practitioners about the effects 
that IHE may have on blood glucose level.  
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In attempt to address some of the limitations outlined in the studies within this review 
the following chapter will outline the IHE protocol and the intervention for insulin and 
carbohydrate adjustment that has been designed for the use within this study.   
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Chapter 3A 
Development of the Intervention and 
the Intermittent High Intensity Exercise 
Protocol 
 
 
The literature review highlights a gap in the evidence base for blood glucose responses 
to IHE in individuals with type 1 diabetes.  Previous literature demonstrates that IHE 
can encompass a range of exercise protocols with varying work to recovery ratios 
however the exercise protocols used are not specific to IHE.  In addition, problems 
managing individuals’ blood glucose concentration may arise during and after IHE due 
to carbohydrate and insulin alterations based on unfounded evidence.  As a result the 
overall aim of this research is to investigate the effectiveness of a structured 
intervention for insulin and carbohydrate adjustment on blood glucose responses during 
and after IHE that replicates team and field based sports in individuals with type 1 
diabetes. 
 
This chapter will outline the design of the intervention used for insulin and carbohydrate 
adjustment throughout this study.  Furthermore the IHE protocol that was designed with 
the aim of replicating team and field based sports activity will also be described.     
 
3A.1 Intervention 
 
Within this study, prior to all the IHE and moderate intensity exercise protocols, 
instructions were given to participants on carbohydrate and insulin adjustment.  This 
was based on a previously devised algorithm for carbohydrate and insulin adjustment 
for moderate intensity exercise in a laboratory environment at 50% OV 2 max (Kilbride 
et al., 2011).  This algorithm was used for exercise performed three hours after a fast-
acting analogue dose.  In response to gaps in the evidence base for guidelines for insulin 
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and carbohydrate administration for IHE the intervention in this study was tested for 
Objectives three and four of this study.   Only the acute physiological responses are 
discussed within this intervention and so the long term effects on glycaemic control are 
not included in this study.  The intervention is shown in Appendix 2 and the following 
provides a discussion of each component within such.       
 
3A.1.1 Pre-Exercise Fast-Acting Analogue Reduction 
 
Fast-acting insulin analogues such as Insulin Aspart or Insulin Lispro are used as a 
bolus injection and have been designed to enable patients with type 1 diabetes to mimic 
the normal meal time insulin response more closely than regular human insulin and 
therefore improve postprandial glycaemic control.  Previous research has demonstrated 
that patients injecting fast-acting analogue insulin at meal times during a basal-bolus 
regime had lower postprandial blood glucose concentration and improved glycaemic 
control when compared to those injecting regular human insulin (Raskin et al., 2000; 
Rabasa-Lhoret et al., 2001).   
 
Where regular human insulin (e.g. Actrapid,Humilin S) has a slow onset of activity (50-
90 minutes) and a prolonged duration of action ( up to 12 hours), fast acting insulins 
taken just prior to a meal or snack have a rapid onset of action (around 0-10 minutes) 
and have a short duration of action (2-5 hours) (Roberstson et al., 2008).  Robertson et 
al (2008) and Noble et al (1998) reported that the peak time of action after injection of 
fast acting insulin analogues is around 40-90 minutes.  Additionally West et al (2010) 
states that regardless of insulin dose the peak time of action after insulin injection is 60 
minutes.  Therefore a high risk time for hypoglycaemia to occur is between 40-90 
minutes after injection.   
 
The magnitude of exercise-induced hypoglycaemia with fast-acting insulin analogues 
will depend in part on the interval between insulin administration and exercise.  
Practical guidelines suggested within the literature have been considered regarding pre-
exercise insulin dose reductions in order to combat this risk of hypoglycaemia (Rabasa-
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Lhoret et al., 2001; Grimm et al., 2004; Pierce, 1999; Toni et al., 2006).  These 
reductions in insulin dose vary from 50-75% during 30 or 60 minutes of cycling at 25, 
50 and 75% OV
2 max (Rabasa-Lhoret et al., 2001), 20-30% for continuous moderate 
exercise over 60 minutes in duration (Grimm et al., 2004), 30-50% for moderate 
exercise (Pierce, 1999) and 70-90% for IHE (Pierce, 1999; Toni et al., 2006).  However 
Noble et al (1998) states that there is no need to reduce the pre-meal fast acting basal 
dose if exercise is three hours after the meal.  
   
For this study the participants were required to exercise three hours following a bolus 
meal related dose.  If the pre-meal dose was reduced three hours prior to exercise then 
the risk of hypoglycaemia is increased.  This is considering the carbohydrate ingestion 
and glucose rise with a reduction in insulin administration.  Considering this combined 
with the peak insulin action suggested by Robertson et al (2008), Noble et al (1998) and 
West et al (2010) the pre-meal bolus dose was not reduced.     
 
3A.1.2 Post-Exercise Fast-Acting Analogue Reduction 
 
Much of the literature regarding post-exercise fast acting analogue reductions in insulin 
dosage is equivocal and limited despite the large evidence base describing LOPEH.  
Literature states that the post exercise basal dose should be reduced in order to prevent 
delayed onset hypoglycaemia after exercise but does not give any suggestion or 
guidelines as to how much to reduce the dose by (Kordi and Rabbani, 2007;  Rabasa-
Lhoret et al., 2001; Perry and Gallen, 2009; Toni et al., 2006).  Some research has 
attempted to make suggestions on how much the fast acting analogue dose should be 
reduced (Lumb and Gallen, 2009; Pierce, 1999).  Lumb and Gallen (2009) suggest that 
the dose should be reduced by 30% whereas Pierce (1999) suggests a 25-50% reduction 
based on exercise intensity.  These guidelines are however not evidence based and were 
simply determined through clinical experience.  Recently Maran et al (2010) 
investigated a 20% reduction in the fast acting insulin dose post IHE or moderate 
intensity late afternoon exercise.  This study observed that IHE poses a greater risk for 
the development of delayed onset hypoglycaemia over moderate intensity exercise, 
despite a reduction of 20% fast acting insulin dose.     
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 Since a previous study (Maran et al., 2010) reduced the evening meal insulin dose by 
20% after a bout of IHE and delayed onset hypoglycaemia was still a problem for 
participants it was decided to up the fast-acting insulin reduction to 30% in Phase 1 of 
this study. Due to the need to replace glycogen stores the meal had to be eaten within 
two hours of finishing exercise.  This 30% reduction in fast-acting analogue dose was 
found to prevent delayed onset hypoglycaemia for 40 minutes of moderate intensity 
walking/jogging at 50% OV
2 max (Kilbride et al., 2011).  Phase 2 of this study further 
reduced the fast-acting insulin dose to 50%.  The justification for this will be outlined in 
Chapter 5: Discussion.    
 
3A.1.3 Carbohydrate Amounts 
 
Limited evidence exists regarding carbohydrate quantities to be consumed prior to and 
during exercise for those with type 1 diabetes, although carbohydrate consumption is 
recommended to prevent hypoglycaemia (Francescato et al., 2004).  Current 
recommendations from the DAFNE group (2002) state that 10g of CHO would raise the 
blood glucose concentration by 2.5 mmol.l
-1
.   
 
This information was used to design the intervention  and informed the design of 
recommended carbohydrate intake depending on pre-exercise blood glucose 
concentration.  If blood glucose concentrations were less than 10 mmol.l
-1
 prior to 
exercise carbohydrate was prescribed as per the intervention.  If blood glucose 
concentrations were 4, 6 or 8 mmol.l
-1
 the amount of carbohydrate taken was 30, 20 and 
10g respectively.   
 
3A.1.4 Pre-Exercise Blood Glucose Targets 
 
Participants aimed to commence exercise with a blood glucose concentration of ~8 
mmol.l
-1
.  Gallen (2005) has suggested that participants should begin exercise with a 
concentration between 7-10 mmol.l
-1
, then in a subsequent publication suggests between 
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7-12 mmol.l
-1 
(Lumb and Gallen, 2009).   When considering the risk of hypoglycaemia 
and also the risk of delaying exercise due to hyperglycaemia, the target of 8 mmol.l
-1
 for 
patients has been selected to represent a typical real life pre-exercise blood glucose 
level. 
   
3A.1.5 Pre-Bed Blood Glucose and Carbohydrate Amounts 
 
Nocturnal hypoglycaemia has been highlighted as a risk following afternoon and 
evening exercise (Lumb and Gallen, 2009) For prevention of this, it has been suggested 
to increase carbohydrate consumption in order to account for increased insulin 
sensitivity and glucose uptake, to restore muscle and liver glycogen (Lumb and Gallen, 
2009) Despite this specific carbohydrate amounts are not suggested anywhere in the 
literature.   
 
Post-exercise a 30% reduction of the following meal analogue dose was given to 
prevent delayed hypoglycaemia.   The intervention was designed to advise individuals 
to take an extra 10-20g of carbohydrate before bed if the blood glucose concentration 
was under 10 mmol.l
-1
.   
 
3A.1.6 Long-Acting Analogue Adjustment 
 
Long-acting insulin Glargine (Lantus) is a basal insulin replacement that resembles the 
basal insulin secretion of a non-diabetic pancreatic beta-cell.  Basal insulin replacement 
should provide a reproducible supply of insulin into the blood stream which will remain 
stable for 24 hours to suppress hepatic glucose production and to facilitate the action of 
bolus insulin (Peter et al., 2005).   
 
Studies on the effects of exercise on the absorption of long-acting basal insulin lantus 
are limited.  Peter et al (2005) reported that 30 minutes of exercise at 65%  OV
2 max 
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did not increase the absorption rate of basal insulin Lantus.   No current evidence exists 
to suggest the need to adjust long acting doses.  Despite some authors simply stating 
that the dose may need reduced (Lumb and Gallen, 2009) long acting doses were not 
adjusted due to the potential hyperglycaemic effects that could occur within the 
following 24 hours.  
 
3A.2 Intermittent High Intensity Exercise Protocol 
 
As previously highlighted in the literature review in Chapter 2 previous research has 
used IHE protocols that are not entirely specific to the demands of intermittent type 
activity.  The intermittent protocol in this research was designed with the aim of 
replicating the physiological demands of team and field based sports as closely as 
possible within the limits of the laboratory.  The mode of exercise for the protocols was 
treadmill running.  This was chosen so that the mode is sport specific to many 
intermittent team sports.  The exercise sessions lasted for 40 minutes to mimic one half 
of a team game.  To account for the differing training statuses of the participants the 
intensity of exercise elicited a treadmill speed that matched a percentage of the 
individuals predicted OV 2max determined from the initial sub-maximal incremental 
walking protocol (Described in Chapter 3B).  
 
Spencer et al (2005) classified movements in team sports into walking, jogging and 
striding/sprinting.  The IHE protocol therefore consisted of cycles of walking at 40% 
OV 2 max for five minutes, jogging at 70% OV 2 max for three minutes and sprinting at 
125% OV 2 for five seconds.  The duration of each bout was determined by matching 
the percentage total time spent in each separate activity pattern during the protocol to 
the observed time motion analysis studies in team sports (soccer, hockey and rugby) 
carried out by Spencer et al (2005).  A sprint time of five seconds was chosen based on 
the average duration of high intensity bouts recorded in the field via time motion 
analysis studies (Abdelkrim et al., 2007; Bloomfield & O’Dooghue, 2007; Duthie et al., 
2005; Spencer et al., 2004; Lothian & Farley, 1994; Bangsbo et al., 1991).  Walking 
and jogging for five and three minutes respectively were chosen since walking and 
jogging together constitute around 73% of game time and thus account for much of the 
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activity performed during recovery from high intensity bouts during games (Spencer et 
al., 2005; Spencer et al., 2004; Lothian & Farley, 1994; Bangsbo et al., 1991).  The 
protocol also considered the deduction in total time required for treadmill speed 
changes.  Although this design is a simplification of the very complex and often 
changing activity and recovery patterns that occur in team games in the field, this is a 
novel protocol for the investigation of blood glucose responses associated with this type 
of activity in a laboratory environment.   
 
This chapter has described the design of the intervention for insulin and carbohydrate 
adjustment and the intermittent exercise protocol.   The following chapter: Methodology 
will go on to detail the research methods, including providing details on the search 
strategy, data collection methods and sample selection.  
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Chapter 3B 
Methodology 
 
In order to address objectives two and three outlined in Section 1.3 of the introduction 
empirical research will be used.  Phase 1 of the empirical research will address objective 
two:  
Compare the effects of a 30% post exercise fast acting analogue insulin reduction on the 
blood glucose responses to a bout of IHE vs. continuous moderate intensity exercise in 
individuals with type 1 diabetes.  
 
Phase 2 of the empirical research will address objective three:  
Compare the blood glucose responses to a 30% vs. a 50% post exercise fast acting 
analogue insulin reduction after a bout of IHE in individuals with type 1 diabetes.  
 
This chapter discusses and justifies the research design and data collection techniques 
that were adopted in the empirical collection of data in this study in order to address the 
research objectives.   Details of sample selection and data analysis techniques are also 
outlined.   
 
3B.1 Research Design 
 
Experimental research in the laboratory was used in order to carry out this study.  The 
justification of conducting experimental research in the laboratory as opposed to the 
field is that the greater control of the experimental arrangements in the laboratory 
enhances the internal validity of the study and makes it far more straightforward to 
replicate the study design.  This is an important aspect in order to reduce experimental 
bias and in order to easily replicate the IHE during the second phase of the study.  
However there is an argument that the ecological validity of a study conducted in the 
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laboratory may be poor as it would be difficult to know how well the findings are 
applicable to exercise that occurs in the real world out in the field.  The research is 
therefore attempting to accurately reflect the nature of IHE common to team sports 
within a controlled laboratory environment as a starting point for further research.  
 
The research design employed initially in Phase 1 of this study was a randomised 
repeated measure cross over design (time x exercise protocol) where each participant 
was randomly allocated to performing the moderate or IHE first.  This was done using a 
list of random numbers.  The participants then performed the other exercise protocol 
two days later.  A repeated measures cross over design allows individual differences in 
the participants to be controlled for as this can often be the largest source of variation in 
many studies (Thomas et al., 2005).  For this reason each participant acted as their own 
control by performing both the moderate and IHE.  In addition through random 
assignment all known and unknown confounders are equally distributed and at the end 
of the study the differences in blood glucose can be attributed to the exercise intensity.  
The comments made justify the reasoning for using a randomised repeated measures 
design for this research.  Phase 2 of the study repeated the IHE exercise protocol with 
and altered intervention that was based on results from Phase 1.  The dependent variable 
and outcome measure for Phase 1 and 2 of the study was blood glucose concentration.  
The independent variable for Phase 1 was the exercise protocol, and for Phase 2 the 
independent variable was the percentage of insulin reduction: 30 v 50%.  The outline of 
the experimental research design can be seen in Figure 3.1.    
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Phase 1 
 
 
 
Phase 2 
 
 
Figure 3B.1. Outline of the Experimental Research Design. 
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3B.2 Participants 
 
A total of 261 patients with type 1 diabetes from a hospital in Edinburgh that matched 
the inclusion criteria (see below) were sent invitation letters (See Appendix 3) in 
September 2010.  A reminder letter was sent one month later to all.  By the end of 
October 2010, 12 participants were interested in participating in the study and 10 
participants had been in touch to decline.  Common reasons for participants declining 
were time commitments, they did not feel fit enough or that they did not participate in 
regular exercise.  In addition a few participants had moved recently onto insulin pump 
therapy.  Only four participants had taken part in the study by January 2011.  It was then 
decided to send invitation letters to a further 99 patients from an additional hospital in 
Edinburgh in February 2011.     
 
Overall a total number of 10 participants were informed of the purpose of the study and 
the possible risks associated with exercise and the use of a Continuous Glucose Monitor 
(CGM).  They all gave informed consent in accordance with Edinburgh Napier 
University and the local NHS Ethics Committee, who approved the study.  A copy of 
the consent form can be seen in Appendix 4.  Unfortunately one participant dropped out 
after the pre-assessment day, one only completed the moderate intensity exercise day in 
Phase 1 of the study and a CGM did not work on one participant for the duration of 
Phase 1.  It was thought that there was insufficient data for these participants so they 
were excluded from the study.  The total number of participants that completed Phase 1 
was seven.  Only six participants returned and completed Phase 2.  The participant 
characteristics are displayed in Table 3.1.   
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Table 3B.1.  Participant Characteristics.  Numbers are displayed as means and standard 
deviations (±).  
 Phase 1 (n = 7) Phase 2 (n = 6) 
Age (Years) 36.6 ± 9.21 36.6 ± 9.94 
 
BMI (kg/m
2
) 25.6 ± 3.05 25.7 ± 3.29 
 
HbA1c (%) 8.3 ± 0.88 8.4 ± 0.91 
 
OV 2 max (ml.kg
-1
.min
-1
) 35.4 ± 4.91 34.6 ± 4.76 
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3B.2.1 Sample Size 
 
A power calculation was performed in order to estimate an appropriate sample size for 
the study.  The sample size calculation for a crossover design was described by Hopkins 
(2009) and estimated a total sample size of 42 participants.  This was where the alpha 
level of statistical significance was set at 0.05 and the smallest change in blood glucose 
was set at 0.5 mmol.l
-1
.  This was chosen as such a small change in blood glucose 
during the exercise protocols could be of clinical significance.  The type II error rate 
was set at 20% since Cohen (1988) recommends having an 80% chance of detecting an 
effect/relationship.  Due to there being insufficient published information in the 
literature about IHE in type 1 diabetes the within subject standard deviation for blood 
glucose was set at 0.8.  This was taken from a study that looked at the responses of 
blood glucose to IHE compared to moderate intensity exercise in individuals with type 1 
diabetes (Guelfi et al., 2005b).  It should be noted however that the approaches to 
sample size estimation provide estimates based on inferences about a population mean 
effect.  Due to the strict inclusion criteria, the significant time commitment required for 
the trials and the specific clinical population required, the participant numbers were 
much lower than this sample size calculation and this reduced the statistical power of 
the study to 13.33% in Phase 1 and 11.4% in Phase 2. 
   
3B.2.2 Inclusion/Exclusion Criteria 
 
The following inclusion/exclusion criteria were applied to the participants in the study: 
 
Inclusion Criteria: 
 Male and Female Age 20-40 
 HbA1c < 10% 
 Type 1 Diabetes for at least two years 
 Not on any other medication other than insulin 
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 Must perform structured exercise for at least 20 minutes or more at least twice a 
week and undertake a mixture of competitive or recreational sports 
 Use a basal bolus insulin regime with analogue insulin and will be experienced 
with carbohydrate counting and insulin dose adjustments 
 
 Exclusion Criteria: 
 Hypoglycaemic unawareness 
 Proliferative retinopathy 
 Peripheral vascular disease 
 Hypertension (resting blood pressure > 160/90 mmHg)  
 Orthopaedic problems  
 
Both male and female participants were included in the research.  Although some 
quantitative differences do exist in the glucoregulatory responses to exercise in men and 
women with type 1 diabetes, the pattern of responses is similar (Galassetti et al., 2002).  
Children and adolescents below the age of 20 were not included to control for any 
effects of hormonal changes and varying levels of insulin resistance at differing stages 
of puberty (Moran et al., 1999).  Only those with reasonable glycaemic control (HbA1c 
< 10%) were allowed to participate in the study to prevent any influence of glycaemic 
control on the results.  Participants must have had type 1 diabetes for at least two years 
since after this duration it will be unlikely that the beta cells will still be producing 
insulin.  Participants could not be on any other medication other than insulin to ensure 
that any pharmacological substances did not influence glycaemic response.  In addition 
selecting participants that are already physically active will likely make them more 
tolerable to exercising at various intensities and therefore should be more likely to 
complete the required exercise bouts.  It was also important that patients are 
experienced with carbohydrate counting and insulin dose adjustments as the research 
involves adjusting insulin and carbohydrate doses, therefore for safety reasons 
participants must understand this.          
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3B.3 Data Collection Tools 
 
The following sections will describe the data collection tools used in this study.   
 
3B.3.1 Pre-Assessment Health Checks  
 
Prior to each exercise session participants gave informed consent and a pre-test health 
and activity questionnaire was administered (See Appendix 5).  Two blood pressure 
(BP) measurements were taken using an automated BP device (Omron) and the two 
readings were averaged to give a final result.  An automated device was used to 
eliminate human errors with the standard sphygmomanometer measurement method.  
Blood glucose concentrations were also checked using a self-blood finger prick.  
 
Standing height was measured using a standard Stadiometer before lowering the 
headboard to touch the vertex of the head.  In this position when the participants head 
was aligned in the horizontal plane the height was indicated by the stadiometer and 
recorded.  Body mass was measured using a balance beam where the participant was 
centred on the scales and were asked to remove their socks and shoes.  
 
3B.3.2 Exercise Protocols 
 
All exercise sessions took place in a sport and exercise science laboratory at Edinburgh 
Napier University, using the same treadmill (Woodway Treadmill ERGO ELG 55) at 
room temperature.   
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3B.3.2.1   Prediction of OV
2
max 
 
Each participant’s predicted OV
2
max was determined using a sub-maximal incremental 
walking protocol on a treadmill.  The test consisted of seven, three minute workloads 
with progressive increments in treadmill speed and gradient (Davison, 1994).  The test 
protocol is outlined in Table 3.2 below.  The sub-maximal protocol was designed to 
encompass the anticipated range or aerobic fitness of the participants, ensure all 
participants completed at least three intensities, ensure a steady state was reached at 
each intensity, ensure that the total test time is not too long and that the treadmill speeds 
will not cause the participants to run.   
 
The participants were given the opportunity to familiarise themselves with walking on 
the treadmill and were fitted with a heart rate monitor (Polar) and a face mask for the 
breath x breath gas analysis (CPX: ECG-VO2 Cortex Biophysik GmbH) to measure 
OV 2.  Prior to testing the computerised gas analysis system was calibrated.  This was 
done by firstly calibrating the volume of air measured and then calibrating the 
concentration of O2 and CO2.   This procedure was carried out on the computerised gas 
analysing system.   
 
During the test HR, OV 2 and Rate of Perceived Exertion (RPE) (Borg, 1982) were 
recorded at the last 30 seconds of each stage.  Blood glucose was also recorded using 
self-testing blood glucose monitoring (TRUEresult Twist Blood Glucose System) at the 
beginning, 10 minutes into the test and at the end of the test.   The end point of the test 
was at or just before 85% of the participant’s age predicted maximum heart, or for 
safety reasons when the monitoring system failed or a participant experienced 
progressive angina, light headiness, confusion, ataxia, nausea, blood glucose drops 
below 4 mmol.l
-1
, they experience feelings of discomfort or they ask to stop.  
Participants maximum predicted heart rate was calculated using the following formulae: 
220-age. This age predicted equation is commonly used as a basis for prescribing 
exercise programmes, as a criteria for achieving maximal exertion and as a clinical 
guide during exercise testing (Tanaka et al., 2001).   
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Table 3B.2.  The sub-maximal incremental treadmill walking test (Davison, 1994). 
Workload Time 
(mins) 
Speed 
(km/h) 
Gradient 
(%) 
Predicted VO2 (ml.kg 
-
1.
min
-1
)  
1 0-3 4 
 
0 10.17 
2 
 
3-6 4.8 2.5 15.9 
3 
 
6-9 5.3 5 20.25 
4 
 
9-12 6 6.5 25.2 
5 
 
12-15 6 9.5 30.6 
6 
 
15-18 6 12 35.1 
7 18-21 6 15 40.5 
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3B.3.2.1.1 Extrapolation of  OV 2 max and Determination of Treadmill Speed 
 
In order to quantify the exercise intensity that each patient would work at during the 
exercise protocols data from the sub maximal walking test was used.  An example from 
one patient can be seen in Appendix 6.  The steady state OV 2 achieved (from the CPX) 
in the last 30 seconds of each workload was plotted against the heart rate obtained at 
each workload and a linear extrapolation was fitted using the following equation, where 
m was the slope, y was the subjects age predicted heart rate maximum and c was the 
intercept (Figure 3.2): 
 
y = mx + c 
 
Using this equation the subjects predicted OV 2 max was obtained (x).  
 
The target OV
2
 was calculated using the following equation (ACSM, 2010): 
 
Target OV 2 = desired % x OV 2 max 
 
This was completed for 40, 50, 70 and 125% OV 2 max, since these were the intensities 
required for the exercise protocols. 
 
In order to determine the treadmill speed that elicited 40, 50, 70 and 125 % of the 
participants OV 2 max the following ACSM equation was used (ACSM., 2010): 
 
OV
2 = 3.5 + (0.2 x speed) + (0.9 x speed) x % gradient 
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The gradient was kept at a constant 1% to account for the energetic cost of outdoor 
running (Jones and Doust, 1996).   
 
According to the ACSM (2010) the direct method of exercise prescription using the 
relationship between heart rate and OV 2 may be particularly useful when prescribing 
exercise in persons who have a chronic condition such as type 1 diabetes that may alter 
the heart rate response to exercise.   
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Figure 3B.2. Example plot of the relationship between OV
2 and HR.  
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3B.3.2.2 Intermittent and Moderate Intensity Exercise Protocols 
 
Each participant performed the exercise protocols at the same time of the day to account 
for any variations in circadian rhythm.  The time chosen was the late afternoon/evening, 
at the end of a working day before the evening meal, since it is thought to replicate the 
most common exercise behaviour amongst patients.  This was apparent during patient 
discussions regarding usual exercise and management.  Other protocols have also 
investigated evening exercise (Iscoe and Riddell, 2011; Maran et al., 2010; Campaigne 
et al., 1987).  This offers the advantage of providing an element of reality by 
stimulating normal conditions under which exercise may be commenced by individuals 
with type 1 diabetes.  
 
The IHE protocol was described in detail in Chapter 3B.  This protocol consist of cycles 
of walking at 40%  OV 2 max for five minutes, jogging at 70% OV 2 max for three 
minutes and sprinting at 125% OV 2 max for five seconds.    
 
The moderate protocol was continuous running at 50% OV 2 max for 40 minutes to 
stimulate the intensity of a light jog.  After the exercise tests a period of active recovery 
for five minutes was administered on the treadmill at a steady walking pace that was 
determined by the participant.   
 
The exercise sessions were terminated if the monitoring systems failed, a participant 
experienced progressive angina, light headedness, confusion, ataxia or nausea.  It was 
also terminated if the participant experienced discomfort and asked to stop or their 
blood glucose fell beneath 4 mmol.l
-1
 or they experienced symptoms of hypoglycaemia. 
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3B.3.3 Instructions for Insulin Dose and Carbohydrate Administration 
 
Chapter 3B provides a detailed explanation of the intervention used in this study.  The 
insulin adjustments in this research are centred around a 30% reduction in the post 
exercise fast acting analogue insulin at the following meal after the exercise sessions for 
Phase 1.  This meal was dinner for all the participants as the exercise was performed 
late afternoon.  For Phase 2 of the research the reduction in post exercise insulin dose 
was 50% for exercise performed in the late afternoon prior to dinner.      
    
3B.3.4 Continuous Blood Glucose Monitor Procedures 
 
In order to measure participants blood glucose concentrations throughout the duration of 
the study a CGM (IPro2: Medtronic) was used and was connected to the participants via 
a sensor.  The sensor will determine how much glucose is in the subcutaneous tissue 
under the skin and will then send a signal to the monitor with this information, therefore 
measuring interstitial blood glucose every five minutes for a maximum time of 72 
hours.  The sensor however did not start recording interstitial blood glucose until one 
hour after insertion.  The Ipro2 CGM system requires repeated calibrations with 
capillary blood glucose values throughout the day.   Participants were thus instructed to 
take a minimum of four self-blood glucose readings with their meter each day at 
standardized times.  These were recorded in the patient diaries and used to calibrate the 
CGM.   
 
It should be noted that the CGM does not directly measure glycaemia, rather its main 
value lies in completing the data obtained during SBGM by permitting visualisation of 
glucose fluctuations between checks of SBGM.  The Ipro2 measures glucose in the 
interstitial space, while self-blood glucose readings with the participants meter measure 
glucose from the vessels (mixed capillaries).  Given that the two testing areas are 
completely separate, the glucose takes time to travel from one area to another, making it 
difficult to extrapolate with certainty glycaemia values measured at a particular instant 
on the basis of interstitial glucose measurements (Melki et al., 2006., Bevlin, 2010). 
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When glucose values are stable, such as in a fasting state, the glucose levels between the 
two areas are almost identical (Bevlin, 2010).  However when glucose levels are 
constantly changing, such as after a meal, the sensor reading may lag behind (Melki et  
al., 2006; Blevins, 2010; Boyne et al., 2003; Monsod et al., 2002).  Boyne et al (2003) 
reported a mean time difference of 4-10 minutes in patients with type 1 diabetes 
following the ingestion of two liquid meals.  In addition Monsod et al (2002) noted a 
delay in blood glucose measured by a CGM on transition from hypoglycaemia to 
hyperglycaemia.  This phenomenon of the physiological effect of insulin on interstitial 
glucose uptake by peripheral tissues can affect the accuracy of the results obtained from 
the CGM.  The recommendation thus for the use of CGMs issued by the Food and Drug 
Administration, state that this device does not provide exact data on blood glucose 
levels but may be used to track changes in glycaemia.       
 
The rationale for the use of the CGM device is that the frequent glucose measurements 
provide a more comprehensive measure of glycaemic excursions than intermittent self-
blood glucose finger pricks which only offer a narrow window.  In addition this CGM 
device did not provide the participant with real-time glucose that could influence their 
actions to control their blood glucose concentrations.  Most importantly from a public 
health standpoint is the ability of the CGM system to detect asymptomatic 
hypoglycaemic episodes and to lower HbA1c (absolute decline of 0.3%) as compared 
with controls (Tavris and Shoaibi, 2004).  The investigations of periods when checks of 
blood glucose are rare for example during the night or after meals have become one of 
the principle indications of continuous recording in routine practice (Melki et al., 2006).  
The nocturnal period has been more extensively studied due to decreased patient 
awareness at this time.  In a study on 10 adults with poorly controlled type 1 diabetes 
(HBA1c = 8.7%) and with normal hypoglycaemia awareness, Cheyne et al (2002) 
observed that in eight patients, one and three episodes of nocturnal hypoglycaemia (< 3 
mmol.l
-1
) were undetected by patients but were detected with the CGM.  The CGM is 
also of value for detecting periods of hyperglycaemia occurring during the daytime 
which may also be overlooked as a result of insufficient adherence to blood glucose 
self-monitoring or monitoring that does not cover the whole day.  The CGM recordings 
permit the detection of a large number of post-prandial hyperglycaemic episodes as well 
as prolonged nocturnal hyperglycaemia (Melki et al., 2006).  This is of particular 
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importance as patients are often trained to monitor blood glucose levels before meals 
and bedtime, but rarely a few hours after.        
 
Therefore the use of the CGM allows a diurnal glucose profile that would otherwise be 
difficult to obtain.  Periods of glucose instability and variability can be detected in order 
to identify the past, present and immediate future of glycaemic status.  Ultimately this 
could lead to a more informed clinical decision in terms of altering carbohydrate and 
insulin doses in relation to exercise.  
 
3B.3.5 Self-Blood Glucose Monitoring 
 
In addition participants were asked to undertake self-testing blood glucose monitoring at 
0, 20 and 40 minutes in relation to the exercise trials using a TRUEresult Twist Blood 
Glucose Meter.  Blood glucose concentration was also monitored immediately after 
exercise and just before the participant leaves the laboratory to ensure that they are 
within safe limits.  A TRUEresult meter was given to each participant at the start of the 
study and they were instructed to use this meter for the duration of the study.  The 
TRUEresult meter was selected since it provides a small meter and strip package that 
makes self-blood glucose monitoring easier and more convenient than conventional 
systems.  In particular having a small “all in one” system means that it is convenient for 
carrying around during exercise.  Results are displayed within four seconds using only 
0.5 microliters of blood (Bell et al., 2009).  First time users have reported that the 
system was very easy to use and that they were able to achieve clinical performance 
equal to that of a trained healthcare professional (Bell et al., 2009).  100% of the health 
care professionals results were within the internationally recognised standards for 
accuracy for both fingertip and alternate sites (forearm) (Bell et al., 2009).     
 
The purpose of using self-blood glucose testing in addition to the use of the CGM was 
to reflect glucose control at specific points in time throughout the exercise bouts in 
order to determine immediate insulin needs in response to hyperglycaemia and 
hypoglycaemia.  In addition the CGM did not start recording blood glucose until one 
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hour after insertion.  Self-blood glucose monitoring accuracy has improved over time 
and has its clinical utility (within ± 10% reference values), (Mastrototaro et al., 2008).  
Additionally Davison et al (Unpublished) compared continuous blood glucose 
monitoring to standard measurement (Onetouch Ultrasmart) during a bout of moderate 
intensity exercise (50% OV 2 max) in individuals with type 1 diabetics and found that 
the two methods were comparable over a large range of blood glucose conentration (r = 
0.79).   
 
3B.3.6 Monitoring Diaries 
 
Patients were given monitoring diaries to complete for the duration of the study.  A 
copy of the diaries given to the participants can be seen in Appendix 7.  These were 
used to record blood glucose concentrations, insulin doses and carbohydrate intake.  
Recording this data is part of day to day self-management and participants will be 
familiar with this.  It has now been recognised by health practitioners that patients 
themselves play a crucial role in collecting useful information by self-monitoring of 
blood glucose when they exercise (Gallen, 2005)    It is acknowledged that this is a 
subjective measure and the accuracy of them is dependent on the participants being 
factitious and conscientious.  Blood glucose concentrations were recorded before each 
meal and if participants felt any symptoms of hypoglycaemia or hyperglycaemia.  The 
usual insulin dose plus the adjusted dose was recorded along with any additional insulin 
administration.  This data collection was essential to ensure that participants have 
followed the intervention.  Carbohydrate intake was also recorded.  Carbohydrate 
counting is an integral part of self-management of which some patients may be utilising 
for insulin dose adjustments.  This may have instilled compliancy in some patients.  The 
importance of the accuracy of carbohydrate counting and the recording of specific time 
points for self-blood glucose readings was emphasized on day one.   
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3B.3.7 Hypoglycaemia Diaries 
 
Hypoglycaemia diaries were also given to participants.  A copy of the hypoglycaemia 
diaries can be seen in Appendix 8.  In this study hypoglycaemia will be defined as: 
participants experiencing symptoms of hypoglycaemia confirmed with a SBGM 
(TRUEresult Twist) with a blood glucose of ≤ 4 mmol.l-1 or a SGBM (TRUEresult 
Twist) reading of ≤ 4 mmol.l-1 without symptoms.  These parameters are in line with 
SIGN guidelines (2010).  Participants will decide if the episode was mild or severe with 
severe requiring help from others.  The time in relation to exercise was recorded as this 
is essential to differentiate between the possible effects of the intervention.  Also the 
treatment method used to treat the episode of hypoglycaemia was recorded as this may 
cause hyperglycaemia or recurrent hypoglycaemia.                  
 
3B.3.8 Heart Rate 
 
During all exercise sessions participants had their HR measured via a HR monitor 
(Polar) whilst they are on the treadmill.  The accuracy of HR monitors has been 
extensively investigated.  HR monitors using electrodes (Polar) produced a mean bias 
and variability of less than 1.0 beat per minute (bpm) throughout their functional range.  
In addition Ruha et al (1997) reported that the Polar recorders were both reliable and 
valid when tested against an ECG.    
 
3B.3.9 Rate of Perceived Exertion 
 
RPE was assessed every 10 minutes throughout the exercise trials using a Borg Scale 
(6-20) of perceived exertion (Borg, 1982).  Participants were asked to indicate any 
number on the scale to rate their overall effort.  A rating of six was associated with no 
exertion at all (sitting/rest) and 20 was associated with the most stressful exercise ever 
performed and you feel at your maximum physical limits.  To improve the accuracy of 
the scale the following instructions were given to each participant (Ehrman et al., 2003): 
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“During the exercise test pay close attention to how hard you feel the exercise work 
rate is.  This feeling should reflect the total amount of exertion and fatigue, combining 
all sensations and feelings of physical stress, effort and fatigue.  Do no concern yourself 
with any one factor such as leg pain, shortness of breath or exercise intensity but try to 
concentrate on your total inner feeling of exertion.  Try not to over or under estimate 
your feelings but be as accurate as you can” (p88). 
 
The scale has been widely researched for its use in both clinical and exercise settings 
(Borg, 1998; Noble and Robertson, 1996).  Since then the scale has been validated and 
has become a standard method of measuring the level of intensity experienced during 
physical activity (Noble and Robertson, 1996).    
 
3B.4 Experimental Procedure 
 
Firstly participants attended the exercise physiology laboratory for a familiarisation 
session during which anthropometric measurements (height and body mass), BP,  
prediction of OV 2  max was performed and a pre-test health and activity questionnaire 
was administered (See Appendix 5).  If resting BP was above 195/60 mm/Hg the 
participants were deemed not suitable to exercise and were referred to their consultant 
physician.  Prior to the OV 2  max prediction blood glucose concentrations were 
checked using a self-blood finger prick and if concentrations were above 17 mmol.l
-1
 or 
below 4 mmol.l
-1
 participants were not allowed to exercise.  In addition participants 
were given information regarding the intervention for insulin and carbohydrate 
adjustment that they would be following for remainder of the study. Familiarisation 
with the moderate and IHE protocols was also performed.  Since the IHE protocol 
requires the participants to run at fast speeds on the treadmill, all participants were 
given a familiarization session on the treadmill to ensure they were fully accustomed 
with the changing speeds during the IHE protocol. 
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3B.4.1  Phase 1 
 
One week later participants returned to the laboratory in the late afternoon to complete 
the moderate or IHE trials, which were administered in a randomised order on days 8 
and 10.   
 
Prior to the first exercise session on day eight the participants were connected to the 
Ipro2 CGM.  The blood glucose sensor was inserted into the abdomen via an intruder 
and after 15 minutes the monitor was then connected to the sensor (See Figure 3.3).  
Once the sensor was successfully sending signals to the monitor it was taped securely 
into place.  Participants were also given monitoring and hypoglycaemia diaries to 
complete from day eight until day 12 and were carefully instructed on their use.     
 
Prior to the exercise sessions participants were asked to undertake self-blood glucose 
testing using a TRUEresult Twist blood glucose meter.  If participants were within safe 
limits to exercise a Polar HR monitor was fitted to record HR throughout the exercise 
trials.   The moderate or IHE trial commenced around 30 minutes after the insertion of 
the CGM.  A warm up of five minutes was completed prior to the exercise protocols at a 
pace set by the participants.   At 0, 20 and 40 minutes in relation to the exercise trials 
RPE (Borg, 1982) and self-blood glucose testing (TRUEresult Twist) was recorded.  On 
completion of the exercise sessions, participants had a cool down for five minutes at a 
pace again set by themselves.  The HR monitor was removed and blood glucose 
concentrations were checked prior to the participant leaving the laboratory to ensure 
they were within safe limits.   
 
3B.4.2 Phase 2 
 
Phase 2 of the study took place a month later when participants were invited back to 
repeat the IHE protocol with different instructions in relation to the intervention.  
Patients were instructed to reduce the post-exercise fast-acting insulin dose by 50% at 
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the following meal.  The IHE protocol remained unchanged and the procedures in phase 
1 on days eight or 10 were repeated, with the same testing conditions and restrictions 
applying.   
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Figure 3B.3. Blood glucose sensor and the IPro2 attached to the abdomen.   
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3B.4.3 Testing Restrictions  
 
All participants were required to adhere to the following restrictions during the period 
of the study.  Participants were instructed to consume a similar diet before each session 
and avoid caffeine, alcohol and structured exercise 24 hours before and after testing.  
Caffeine can decrease insulin sensitivity (Keijzers et al., 2002), while alcohol can 
increase the risk of hypoglycaemia in those with type 1 diabetics (Turner et al., 2001).  
In addition it has been found that antecedent exercise can blunt the metabolic and 
glucoregulatory response to subsequent exercise (Galassetti et al., 2001).   
 
Participants were asked to keep a diary of food intake, insulin dose, blood glucose, 
physical activity levels and hypoglycaemic episodes before each meal, four times a day 
on exercise days and 24 hours before and after the exercise days for Phase 1 and 2 of the 
study.  If a participant experienced a period of hypoglycaemia 24 hours before testing 
the session was rescheduled as prior hypoglycaemia can induce counter regulatory 
failure (Galassetti et al., 2003). 
 
3B.5 Data Analysis  
 
All demographic information was contained on the diabetes management database 
within NHS Lothian.  All data analysis out with the NHS was anonymous and names 
were replaced with a participant number.  Data were stored in a secure place in to which 
only the researcher and academic supervisors had access too.  
 
3B.5.1 Analysis of Continuous Glucose Monitor Data 
 
After completion of phase 1 and phase 2, CGM data was uploaded using Solutions 
Software (Medtronic) and stored on an online database that was password protected.  
For each participant the full results were analysed and blood glucose readings were 
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recorded from the IPro2 at the following meal time after exercise and 2, 4, 6, 8, 10, 12 
hours after the meal and at breakfast time the following day.  These time points were 
chosen in order to standardise the times for all participants and to ensure that there was 
an accurate portrayal of blood glucose excursions during the night after the exercise 
bouts.  In addition it was thought that these times would relate to specific points in the 
intervention.  From the evening meal until six hours after this would relate to the 
bolus/meal reduction in insulin dose.  This was what was reduced for the participants.  
From six hours until breakfast the following day this would relate to the basal/long- 
acting insulin dose and the amount of carbohydrate advised to be taken before bed. 
 
The number of hypoglycaemic episodes (blood glucose level of  ≤ 4 mmol.l-1)  was also 
calculated at each time point and these were checked against the hypoglycaemic diary 
entries to assess whether the participants were aware that they had experienced a 
hypoglycaemic episode.  In addition the percentage time spent within the ideal blood 
glucose range (4-8 mmol.l
-1
) was also calculated within each time point for each 
participant.     
 
3B.5.2 Statistical Analysis 
 
Statistical analysis was completed using a Statistical Package for Social Sciences 
(PASW Statistics v 18).  To determine the effectiveness of the intervention for the first 
phase of the study the responses from the CGMs was compared on the moderate and 
IHE exercise days and up to breakfast the following day after the exercise bout.  For 
Phase 2 of the study the blood glucose response from the CGMs was compared to the 
adjusted intervention for IHE.   
 
Results for HR, RPE and blood glucose values were presented as means and standard 
deviations.  All data for Phase 1 and 2 was checked for suitability of parametric analysis 
and then analysed using a two-way repeated measures ANOVA (time x exercise 
protocol) with appropriate checks for sphericity.  Effect size statistics were also reported 
to convey whether any observed differences are substantively important.  Post Hoc tests 
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(Bonferroni) were used to determine where, if any differences lie. Statistical 
significance was accepted at the p < 0.05 level. 
 
This chapter has provided the rationale and details of the research design used within 
this study.  In addition it has outlined the sample selection procedures, data collection 
tools, procedures and data analysis methods.  The next chapter : Results, - will display 
the outcomes of the empirical data collection.   
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Chapter 4 
Results 
 
 
The previous chapter: Methodology, outlined the empirical research design and data 
collection techniques that were carried out in order to address research objectives two 
and three outlined in Section 1.3 of the Introduction chapter.  Phase 1 of the empirical 
research addressed objective 2 which aimed to compare the effects of a 30% post 
exercise fast acting analogue insulin reduction on the blood glucose responses to a bout 
of IHE vs. continuous moderate intensity exercise in individuals with type 1 diabetes.  
Phase 2 of the empirical research addressed objective three which aimed to compare the 
blood glucose responses to a 30% vs. a 50% post exercise fast acting analogue insulin 
reduction after a bout of IHE in individuals with type 1 diabetes.  
 
This chapter will therefore outline the outcomes of the data collection methods in order 
to address the aforementioned objectives.  In the first instance results of Phase 1 will be 
discussed, followed by results of Phase 2 from the empirical research.   
 
4.1 Preliminary Analysis 
 
HR and RPE values were averaged across all three exercise conditions: 30% Moderate, 
30% IHE and 50% IHE, for each participant.  A one-way repeated measures ANOVA 
was conducted to compare the mean HR scores during each exercise condition (30% 
Moderate: 100 ± 5.8; 30% IHE: 108.5 ± 14.9; 50% IHE: 102.1 ± 10 bpm).  Results 
show that there were no effects of exercise condition on HR scores [F(2,10)= 1.05, 
p=0.38].  Results here are presented as mean and standard deviation (±).   
  
A one-way repeated ANOVA was also used to compare the mean RPE scores under 
each exercise condition (30% Moderate: 8.6 ± 1.8; 30% IHE: 9.5 ± 1.7; 50% IHE: 10 ± 
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1.8) .    There were also no effects of exercise condition on RPE scores [F(2,10)= 2.86, 
p=0.10].  Partial eta-squared (ηp
2
) values for HR (0.17) and RPE (0.3) indicate that there 
is a large effect size despite the differences in mean scores being relatively small and 
failing to reach statistical significance.  Again results are presented as mean and 
standard deviations (±).   
 
4.2 Blood Glucose Responses 
 
Blood glucose responses were measured by SBGM (TRUEresult Twist Meter) before, 
during and at the cessation of the exercise bouts.  From the following meal after the 
exercise until breakfast the following day blood glucose concentrations were then 
measured and reported using the CGM (IPro2).  The blood glucose results reported 
using the CGM (Ipro2) are all reported as interstitial blood glucose values.     
 
4.2.1 Pre-Exercise 
 
According to the instructions given to the participants within the intervention for 
carbohydrate and insulin adjustment, the intervention stated that participants should 
commence exercise with a starting blood glucose concentration of 8 mmol.l
-1
.  The 
intervention suggested that additional carbohydrate should be taken if blood glucose 
concentrations were under 8 mmol.l
-1
 prior to the commencement of exercise.  Prior to 
the moderate exercise and the 30% IHE protocol starting blood glucose concentrations 
were within 4-6 mmol.l
-1
 in two participants therefore 20g of carbohydrate was 
administered in the form of dextrose tablets as per the intervention.  The means and 
standard deviations for starting blood glucose concentrations prior to each exercise 
condition are presented in Table 4.1.  A one-way repeated measures ANOVA revealed 
that there was no significant difference between starting blood glucose concentrations 
across the three exercise protocols [F(2,12)= 1.11, p= 0.35, ηp
2
 = 0.15].  
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Table 4.1.  Descriptive Statistics for Starting Blood Glucose Concentrations prior to 
30% Moderate, 30% IHE and 50% IHE Exercise Conditions.  
Exercise Condition N Mean Standard Deviation 
30% Moderate 7 9.3 
 
1.8 
30% IHE 
 
7 9.6 1.3 
50%  IHE 
 
6 10.8 2.2 
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4.2.2 Phase 1: 30% Moderate vs 30% IHE  
 
The blood glucose responses for Phase 1 of the research can be seen in Figure 4.1.  
Figure 4.1 demonstrates that the pattern of response for both IHE and moderate 
intensity exercise throughout the entire monitoring period is similar.  Starting blood 
glucose levels are similar (MOD: 9.3 mmol.l
-1
; IHE: 9.6 mmol.l
-1
) and by the end of the 
exercise session blood glucose had declined under both conditions (MOD: -2.9 mmol.l
-
1
; IHE: -3.6 mmol.l
-1
).  Between the end of exercise and the meal time/insulin reduction 
blood glucose continues to decrease to 5.5mmol.l
-1
 in IHE, but increases to 8.2 mmol.l
-1
 
in MOD.  From the meal onwards all blood glucose readings are now interstitial 
measurements recorded by the CGM.  Interstitial blood glucose profiles for both IHE 
and MOD increase from the meal to a peak at four hours post (MOD: 13.1 mmol.l
-1
; 
IHE: 11.7 mmol.l
-1
).  One participant under the MOD condition recorded an interstitial 
blood glucose value of 18 mmol.l
-1
, indicating that hyperglycaemia in the hours 
following the meal could also be a problem.  Standard deviation values are noticeably 
high throughout under both conditions but tend to be the highest at two hours and four 
hours after the meal.  From six hours onwards the blood glucose profiles declined under 
both conditions until 10 hours where they levelled off until breakfast (MOD: 7.4 
mmol.l
-1
; IHE:7.6 mmol.l
-1
).   
             
A two-way repeated measures ANOVA (time x exercise) was conducted to examine the 
impact of exercise intensity (30% Moderate vs. 30% IHE) on blood glucose 
concentrations.  The main effect for exercise condition [ F(1,6)= 0.32, p= 0.59] and the 
interaction effect [F(10,60)= 0.71, p= 0.70] did not reach statistical significance.  The 
ηp
2
 statistic reported for exercise condition and the interaction effect was 0.05 
(moderate) and 0.10 (large) respectively.   
 
There was a statistically significant main effect for time [F(10,60)= 4.81, p = <0.001]; 
the effect size was large (ηp
2 
= 0.44).  Post Hoc comparisons using Bonferroni picked up 
no significant differences between any of the time points.  This was likely due to the 
number of comparisons, the small sample size and the fact that Bonferroni is a very 
conservative test.  
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Figure 4.1.   Mean blood glucose concentrations during 40 minutes of IHE and 
Moderate exercise and up to breakfast the next day following a 30% insulin reduction at 
the following meal post exercise.   
Arrow indicates start of CGM (IPro2) readings and a shift from self-blood glucose 
readings to interstitial blood glucose readings.  In addition the arrow indicates time of 
30% insulin reduction. Values are presented as means and ± standard errors for 30% 
IHE (▲) and 30% Moderate (•).   
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4.2.3 Phase 2: 30% IHE vs 50% IHE 
 
The trend of the blood glucose profile for both the 30% and 50% intervention in IHE is 
displayed in Figure 4.2 and alike Phase 1, the two profiles are similar throughout the 
entire monitoring period.  Mean reduction in blood glucose from the start to the end of 
the exercise sessions were similar under both conditions (30% IHE: -3.6 mmol.l
-1
; 50% 
IHE -3.4 mmol.l
-1
).  From tea up to four hours blood glucose rises under both 
conditions, with a greater peak at two and four hours under the 50% IHE condition (2h: 
15.3 mmol.l
-1
; 4h: 14.3 mmol.l
-1
), indicating hyperglycaemia risks at these times.  Again 
standard deviation values were high at all points across both trials with the highest 
values being evident at 2h and 4h after the meal.  From four hours onwards blood 
glucose levels decline under both conditions until 10-12 hours post meal. 
         
A two-way repeated measures ANOVA (time x protocol) was conducted to examine the 
difference between the 30% insulin reduction and the 50% insulin reduction following 
IHE and their impact on blood glucose concentration over time.  There was no 
significant main effect for exercise condition [F(1,5)= 5.46, p= 0.06]; ηp
2
 = 0.52].  There 
was also no significant interaction effect [F(10,50)= 0.70, p= 0.71]; ηp
2
 = 0.12.     
 
Similar to Phase 1 there was a statistically significant main effect for time [F(10,50)= 
6.88, p= <0.001]; the effect size was again large (ηp
2
 = 0.58).  Post hoc comparisons 
using Bonferroni showed that there was a significant difference between 0 minutes (M = 
9.5 ± 0.3 mmol.l
-1
) and 40 minutes (M = 6.0 ± 0.3 mmol.l
-1
) in relation to the exercise 
(p = 0.002).  All other comparisons were not significant.   
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Figure 4.2.  Mean blood glucose concentrations during 40 minutes of IHE and up to 
breakfast the following day with a 30% insulin reduction or a 50% insulin reduction at 
the following meal post exercise.  
Arrow indicates start of CGM (IPro2) readings and a shift from self-blood glucose 
readings to interstitial blood glucose readings.  In addition arrow indicates time of 30% 
or 50% reduced insulin injection. ▪ indicates a significant difference from time point 0 
minutes exercise. Values are presented as means ± standard errors for 30% IHE (▲) 
and 50% IHE (•).   
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4.3 Time Spent in Ideal Range 
 
The percentage time spent within the ideal range (4-8 mmol.l
-1
), above and below this 
range was recorded post laboratory period using the CGM and can be seen in Table 4.1.  
Ideally a three-way ANOVA (Exercise Protocol x Time x Range) could have been used 
in order to analyse this data.  However due to the sample size being very small (n= 7 for 
Mod vs 30% IHE; n= 6 for follow up 50% IHE) and the skewness of the data this was 
not possible.  There are also very large standard deviation values (often higher than the 
mean value), indicating that statistical analysis would not be appropriate.  It is for this 
reason that a descriptive analysis alone will be used when discussing the percentage 
time spent within the ideal blood glucose range.   
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Table 4.2.  Percentage time spent above, below and within the ideal blood glucose range (4-8 mmol.l
-1
 ) as measured by CGM post-laboratory period for 
30% MOD, 30% IHE and 50% IHE exercise conditions.  Data are presented as means and ± standard deviations.   
  30% MOD 
 
30% IHE 50% IHE 
 
 Ideal (%) 56 ± 37.7 39 ± 30.2 26 ± 28.1 
Tea-6h Above (%) 42 ± 39.5 61 ± 30.6 69 ± 26.6 
 
 
 
6h-
Breakfast 
Below (%) 
 
 
Ideal (%) 
Above (%) 
Below (%) 
2 ± 4 
 
 
62 ± 40.3 
24 ± 32.3 
14 ± 36.9 
0.57 ±1.5 
 
 
56 ± 27.3 
39 ± 29.7 
5 ± 8.5 
5 ± 6.1 
 
 
49 ± 14.1 
44 ± 23.7 
7 ± 9.8 
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4.3.1 Phase 1: 30% Moderate vs 30% IHE 
 
Tea-6h 
The percentage time spent within the ideal range from tea -6h appears to be greater in 
the 30% Moderate condition compared to the 30% IHE condition (Table 4.1).  However 
the percentage time spent within the ideal blood glucose concentrations ranged from 5-
100% in the moderate condition and 0-73% in the 30% IHE condition for all seven 
participants.  One participant in the moderate condition spent 100% of the time in the 
ideal range, however no-one under the 30% IHE condition spent 100% in ideal.  In both 
exercise conditions only one participant spent any time below the ideal range (< 4 
mmol.l
-1
).  Time spent above the range (> 8 mmol.l
-1
) was greater in the 30% IHE 
condition (Table 4.1) and one person spent 100% of the time with a blood glucose level 
above 8 mmol.l
-1
.  The range of time spent above the ideal for all seven participants was 
16-94% and 26-100% in the moderate and 30% IHE conditions respectively.         
 
6h-Breakfast 
The percentage time within the ideal range appears to still be greater under the moderate 
exercise condition (Table 4.1), where two participants spent 100% of the time between 
4-8 mmol.l
-1
.  The range for all seven participants was 2.2-100%.  Within the 30% IHE 
condition only one person spent 100% time within the ideal blood glucose concentration 
and this ranged from 20-100%.  Within the moderate condition one participant spent 
97.7% of the time below 4 mmol.l
-1
; whereas two participants recorded blood glucose 
concentrations < 4 mmol.l
-1
 (13 and 20% of the time) under the 30% IHE condition.  
Time spent above the ideal range for both conditions is now less compared to tea-6h 
(Table 4.1).  The range for all seven participants for the percentage time spent above 8 
mmol.l
-1
 was 4-80% and 0-80% in moderate and 30% IHE conditions respectively.      
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4.3.2 Phase 2: 30% IHE vs 50% IHE  
 
Tea-6h 
The 50% insulin reduction condition resulted in a greater percentage of time spent 
above the ideal range in comparison to the 30% insulin reduction condition (Table 4.1).  
One participant spent 100% of the time under the 50% IHE condition above 8 mmol.l
-1
.  
The range of time spent above the ideal range for the six participants in the 50% IHE 
condition was 27-100%.  In comparison to the 30% IHE, under the 50% IHE a greater 
time was spent below and a lesser amount of time was spent at the ideal range (Table 
4.1).  Despite the time spent in the ideal range appearing to be relatively small the range 
for all six participants was 0-72%.     
 
6h-Breakfast 
The time spent above and below the ideal range is greater under the 50% IHE condition 
in comparison to the 30% IHE condition (Table 4.1).  Only two participants out of the 
six spent anytime below 4 mmol.l
-1 
(17 and 18% of the time) in the 50% IHE condition.  
This is similar to the 30% condition where again two participants recorded blood 
glucose concentrations below the ideal range (13 and 20% of the time).  The range of 
time spent above the ideal range in the 50% IHE condition is not as great in comparison 
to the range spent above in the 30% IHE condition (14-65% vs 0-80% for 50% and 30% 
IHE respectively).  In comparison to 30% IHE the time spent within the ideal range is 
less for 50% IHE (Table 4.1).  This ranged from 34-68% for the six participants in the 
50% IHE condition.    
 
4.4 Hypoglycaemia Episodes 
 
Ideally a one-sample chi-squared test could have been used to analysis the 
hypoglycaemic episodes recorded under each condition, however again due to small 
numbers this was not possible.  It is for this reason that a descriptive analysis alone will 
be used to discuss the results of this data.  
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In line with SIGN guidelines (2010) hypoglycaemia in this study was defined as: 
participants experiencing symptoms of hypoglycaemia confirmed with a SBGM 
(TRUEresult Twist) with a blood glucose of ≤ 4 mmol.l-1 or a SGBM (TRUEresult 
Twist) or CGM (Ipro2) reading of ≤ 4 mmol.l-1 without symptoms.  Over the course of 
the study a total of 15 hypoglycaemia episodes (Moderate = 5; 30% IHE = 6; 50% IHE 
= 4) were recorded either via SBGM during the exercise trials or by the CGM post-
laboratory period.  The time in which these episodes took place and under which 
exercise condition these occurred can be seen in Figure 4.3. 
 
 
Of the seven participants that took part in the first phase of the study two during the 
moderate exercise protocol and one during the 30% IHE protocol experienced a 
hypoglycaemic episode between 20-40 minutes in relation to the exercise.  These 
exercise trials were terminated and the participants were treated with carbohydrate as 
per the intervention.  Of the six participants that took part in the follow up 50% IHE 
trial, one experienced an episode during 20-40 minutes of exercise and the trial was 
again terminated and the participant was treated with carbohydrate.   
 
Between the following meal after exercise (CGM Tea) and up to breakfast the next day 
the CGM was used, along with the hypoglycaemia diaries to determine if any 
hypoglycaemic episodes occurred.  A total of 12 episodes were recorded using the 
CGM however only five of these were recorded in the diaries.  A total of seven episodes 
(Moderate: 1 x tea, 1 x 6h, 1 x 8h; 30% IHE: 1 x 10h, 1 x Breakfast; 50% IHE: 1 x tea, 
1 x 10h) went unrecorded indicating that the participants were unaware that they were 
experiencing hypoglycaemia at these times.  Two participants who experienced a 
hypoglycaemic episode during the exercise then had a further hypoglycaemic episode at 
the following meal time.  This was regardless of exercise condition.  
 
This chapter has outlined the empirical findings that addressed research objectives two 
and three in sub-section 1.3 of Chapter 1.  The next chapter will go on to analyse and 
synthesize these empirical findings, bringing together the findings from the literature 
review in Chapter 2.     
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Figure 4.3.  Total number of hypoglycaemia episodes recorded during exercise and up 
to breakfast the following day in 30% MOD, 30% IHE and 50% IHE conditions.   
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Chapter 5 
Discussion 
 
 
The previous chapter: Results, outlined the empirical findings from the data collection 
that addressed research objectives two and three of this study.  In the first instance the 
findings of research objective two (Phase 1) of this research will be discussed, followed 
by a discussion of the results from research objective three (Phase 2).   Analysis and 
synthesis will take place in terms of comparing the 30% insulin reduction on the blood 
glucose responses to moderate intensity exercise compared to IHE and followed by 
comparing the 30% vs 50% insulin reductions to the blood glucose responses after IHE.  
In addition the empirical findings will be compared and contrasted to the findings of the 
literature review in Chapter 2.       
 
5.1 Phase 1: Comparison of the Effects of a 30% Post-Exercise Insulin 
Reduction on Moderate and IHE.   
 
The literature review in Chapter 2 demonstrated that advice for those individuals with 
type 1 diabetes wanting to take part in IHE is often conflicting and difficult to interpret.  
One of the largest issues is that current recommendations do not attempt to differentiate 
between continuous moderate intensity exercise and IHE and similar management 
strategies are suggested for both (Grimm et al., 2004; Birrer and Sedaghat, 2003; Pierce, 
1999).  It was also apparent that any recommendations that were available had not been 
tested in practice.  Consequently research objective two attempted to address this issue 
by comparing blood glucose responses to moderate and IHE.  This study showed that 
there was no difference between the decline in blood glucose concentration during 
moderate or IHE exercise performed in the late afternoon.  Despite a 30% post exercise 
fast acting insulin reduction, both IHE and moderate intensity exercise is characterized 
by delayed risk in developing LOPEH in some participants.  As well as hypoglycaemia, 
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hyperglycaemia may also be a problem for some participants following the insulin 
reduction.    
       
5.1.1 Blood Glucose Responses to Exercise 
 
This research has found similar acute blood glucose responses to two differing forms of 
exercise that were identical in duration but differed in intensity (IHE: -3.6 ± 2.3; MOD: 
-3.2 ± 2.6 mmol.l
-1
).  As expected there was a decline in blood glucose concentration 
with continuous moderate intensity exercise.  This has been previously demonstrated in 
other studies that investigated the effects of blood glucose responses to moderate 
intensity exercise in individuals with type 1 diabetes (McMahon et al., 2007; 
Francescato et al., 2004).  The decline in blood glucose concentration that occurs during 
moderate intensity exercise has previously been attributed to the inability of injected 
insulin levels to lower at the onset of exercise, therefore causing impaired glucose 
production and high rates of glucose disposal (McMahon et al., 2007; Wasserman and 
Zinman, 1994).  The similar decline in blood glucose concentration for IHE was 
however surprising since previous research has suggested that IHE can attenuate the 
drop in blood glucose concentrations associated with moderate intensity exercise 
(Bussau et al., 2007; Guelfi et al., 2007a; Guelfi et al., 2005b; Ford et al., 1999).  The 
stabilisation of blood glucose concentration following IHE in previous literature has 
been associated with elevated catecholamines and growth hormone as a result of the 
repeated bouts of high intensity exercise (Guelfi et al., 2005b).   
 
The similar reduction in blood glucose concentration for the two different exercise 
intensities in this study is in agreement with Maran et al (2010) and Iscoe and Riddel 
(2011) and was evident despite methodological differences in the exercise protocols 
performed in each study.  One possible explanation for the similar decline in blood 
glucose concentrations in this study could be that the total energy expenditure and the 
total work performed was the same for both exercise trials.  It is acknowledged that 
energy expenditure and total work was not measured in this study;  however there was 
no difference between average heart rate or RPE score for each exercise trial.  Other 
studies confirm that if two types of exercise are different in intensity but similar in 
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energy expenditure, heart rate and oxygen consumption, then the glycaemic responses 
are reproducible (Iscoe and Riddell, 2011; Maran et al., 2011; Sills and Cerny, 1983).  
 
In contrast Guelfi et al (2005b) found that their IHE (40% OV 2   peak with 4 second 
sprints every 2 minutes) and moderate intensity exercise (40% OV 2   peak for 30 
minutes) differed in total work performed and heart rate responses, thus potentially 
explaining in part why discrepancies between this study and the one described by Guelfi 
et al (2005b) have been found.  In addition the exercise performed in this study was a 
greater duration (40 minutes), a different exercise mode (treadmill running) and of a 
different intensity to that of Guelfi et al (2005b).  Further explanations for the 
discrepancies between this study and other previous research (Guelfi et al., 2005b) 
could in part be due to the time of the day in which the exercise was performed.  This 
study performed the exercise in the late afternoon, however Guelfi et al (2005b) 
performed the exercise sessions first thing in the morning.  It has previously been 
demonstrated that blood glucose responses can be quite different for the same exercise 
performed at different times of the day and at different post-prandial times (Francescato 
et al., 2005).       
 
5.1.2 Blood Glucose Responses Post-Exercise 
 
All blood glucose values reported after exercise are reported as interstitial blood glucose 
levels as recorded by the CGM.  Between 40 minutes at the end of exercise and the meal 
time, interstitial blood glucose concentrations continued to decrease after the IHE but 
appeared to increase after the moderate exercise.  The decline in interstitial glucose 
concentrations in IHE in comparison to the moderate intensity exercise could be 
explained by the fact that IHE is likely to use predominately more muscle glycogen as a 
fuel source since the intensity of exercise would be expected to be higher (Guelfi et al., 
2007a).  Recovery blood glucose concentration may then decline to a greater extent 
because of the increased need for glycogen replenishment and restoration.  Glycogen 
utilisation has not been measured in this study however it has been demonstrated 
previously that IHE uses more muscle glycogen than moderate intensity exercise (Iscoe 
and Riddell, 2011; Guelfi et al., 2007).   Despite blood glucose concentrations rising 
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from the end of the moderate exercise until tea time one participant still experienced 
hypoglycaemia at tea time.  This highlights that individuals differ in their sensitivity to 
exercise and individualised management strategies should be considered.    
 
Post-hoc tests demonstrated, however, that regardless of exercise condition there was no 
difference between blood glucose concentrations at 40 minutes exercise and the CGM 
reading at meal time.  Regardless, a total of three hypoglycaemic episodes were 
recorded at the meal time (IHE: 2; MOD: 1).  One participant in the moderate and one 
in the IHE condition experienced hypoglycaemia at the end of the exercise and again at 
the following meal time.  This could demonstrate stimulation of glucose uptake for the 
repletion of muscle glycogen stores that were used up during the exercise bout.  From a 
type 1 diabetes perspective it may be important to consider consuming a carbohydrate 
snack immediately after exercise in order to prevent further decline in blood glucose 
concentrations prior to the following meal.  This may be particularly important if the 
exercise performed is of a high intensity nature such as IHE.   
 
At present, advice in the research is limited on the best way to deal with post-exercise 
reductions in insulin dose.  Much of the research is focused around pre-exercise dose 
reductions and advice can vary from 25-90% reductions depending on intensity and 
duration of exercise (Toni et al., 2006; Grimm et al., 2004; Rabasa-Lhoret et al., 2001; 
Pierce, 1999).  The purpose of the post-exercise 30% insulin dose reduction in this 
study was to help preserve blood glucose concentration and prevent hypoglycaemia 
both in the short term and long term following exercise.  This was thought to be 
important due to the increased insulin sensitivity that occurs following exercise (Lumb 
and Gallen, 2009).   
 
The interstitial blood glucose profiles for both IHE and moderate exercise increased 
from meal time up to a peak at four hours following the meal.  There were also no 
hypoglycaemic episodes recorded between two and four hours post meal and a high 
percentage of time was spent above the ideal range under both exercise conditions 
(Table 4.2).   This rise in interstitial blood glucose was expected due to the consumption 
of a meal and the administration of the insulin dose at meal time which acts to decrease 
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blood glucose concentration.  All patients in this study were on fast acting insulin 
(Lispro or Aspart), which have a quick onset (0-20 minutes) and peak around 40-90 
minutes (Noble et al., 1998).  The peak in interstitial blood glucose concentrations in 
this study around two hours demonstrates the time action of the insulin and in part the 
food absorption.  It should be noted that hyperglycaemia (blood glucose > 10 mmol.l
-1
) 
was an additional problem, in particular at two – four hours after the meal (Figure 4.1).  
This could have been a result of the continued output of glucose from the liver after 
exercise and too great an insulin reduction with the following meal (Kordi and Rabbani, 
2007).  Just as hypoglycaemia is a problem that should be addressed, equally 
hyperglycaemia is dangerous and if left untreated can lead to ketoacidosis and the 
production of ketones (Kordi and Rabbani, 2007).  In addition frequent bouts of 
hyperglycaemia can lead to long term organ damage such as diabetic retinopathy, 
neuropathy, and cardiovascular disease (Pierce, 1999).        
    
The particularly high standard deviation values at two and four hours post-meal could 
attest to the wide glucose fluctuations in post-prandial glucose excursions between 
individuals.  One factor that could explain this is the meal composition that would affect 
gastric emptying.  The meal content for the participants was not standardized within this 
study therefore every individual would have ingested a meal with varying carbohydrate, 
fat and protein content.  In individuals with type 1 diabetes the total amount of 
carbohydrate consumed has the greatest influence on glycaemia (Sheard et al., 2004).  
Carbohydrate with a low glycaemic index (GI) digests at a slower rate than 
carbohydrate with a high GI (Thomas et al., 2007).  Peak interstitial blood glucose 
responses would therefore be greater in those participants that consumed carbohydrate 
of a high GI content compared to those that consumed lower GI carbohydrates, resulting 
in the large variation in the blood glucose responses seen at two and four hours after the 
meal. West et al (2011) suggests that a low GI meal may be best for maintaining normal 
blood glucose ranges post exercise in those with type 1 diabetes.  Although individuals 
were instructed to consume a similar meal content after all the trials it is acknowledged 
that the lack of standardization of the meal content between participants may limit the 
ability to demonstrate the true impact of the intervention.     
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In addition it is acknowledged that additional factors such as pre-meal plasma insulin 
levels and the reproducibility of insulin absorption between participants may also attest 
to the large variation in interstitial blood glucose concentration at this particular time 
after the meal.  It is however beyond the scope of this research to discuss every possible 
variable affecting the blood glucose response.   
 
From six hours onwards the trend in interstitial blood glucose concentrations declined 
under both exercise conditions then began to level off again around 10-12 hours post 
meal.  The greatest percentage of time spent within the ideal blood glucose range 
between six hours-breakfast was found in the moderate exercise condition (62 ± 40.3 
compared to 56 ± 27.3 % in IHE).  Despite this, standard deviations here are again high 
indicating the large variation between the participants in their blood glucose responses.  
It is also important to note that from six hours onwards in both exercise conditions 
hypoglycaemia was evident (Moderate: 2 incidents; IHE: 3 incidents).  In a similar way 
to Isoce and Riddell (2011) this study found that IHE was associated with a more 
delayed drop in blood glucose concentration since hypoglycaemia did not occur until 
eight hours post, in comparison to six hours in the moderate condition.  This could 
indicate a more delayed response to the increase in insulin sensitivity following 
exercise.    
 
Unfortunately there is very little data available on the blood glucose responses in 
prolonged recovery following exercise, particularly IHE.  Only two studies have 
previously investigated the risk of nocturnal hypoglycaemia after moderate and IHE by 
using a CGM (Iscoe and Riddell, 2011; Maran et al., 2010).  Maran et al (2010) found 
that IHE is associated with an increased risk of LOPEH over moderate intensity 
exercise, in non-trained individuals with type 1 diabetes.  This was despite a 20% 
insulin reduction at the evening meal.  In contrast Iscoe and Riddell (2011) provided 
their participants with a 30g carbohydrate drink at bedtime and found that in 
comparison with moderate intensity exercise, IHE has less risk of developing LOPEH.   
 
The differences between these studies (Iscoe and Riddell, 2011; Maran et al., 2010) and 
results from this one could be attributed to differing interstitial blood glucose 
99 
 
concentrations at bed time and the advice given in terms of insulin and carbohydrate 
adjustment.  All participants in this study were instructed to aim for a blood glucose 
level of around 10 mmol.l
-1
  prior to bed, however in the other studies blood glucose 
concentrations at bed time are unknown (Iscoe and Riddell, 2011; Maran et al., 2010).   
 
The mechanisms thought to contribute to the increased risk of LOPEH after exercise are 
increased uptake of glucose into the muscles to restore muscle glycogen, increased 
insulin sensitivity, impaired counter regulatory responses due to previous 
hypoglycaemia and the timing of the meal and insulin doses (MacMahon et al., 2007).  
This study was not designed to evaluate these mechanisms and therefore it is not clear 
what factors determine the timing of this risk.   
 
From a type 1 diabetes perspective the fact that LOPEH is a risk for participants taking 
part in afternoon exercise may be an important observation, particularly since the 
hypoglycaemic episodes recorded could be coincident with sleep and that sleep may be 
a contributing factor to the increased risk for hypoglycaemia.  This has previously been 
demonstrated in another study who investigated adolescents with type 1 diabetes 
exercising at a moderate intensity in the afternoon (Mcmahon et al., 2007).    
 
Participants in this study were also unaware at certain points that they were 
experiencing hypoglycaemia.  At six and eight hours in the moderate condition and 10 
hours and breakfast in the IHE condition, the hypoglycaemic episodes were not 
recorded by the participants in the diaries.  All participants were screened prior to 
participation in the study and none had a problem of hypoglycaemia unawareness.  One 
potential explanation for the hypoglycaemic unawareness during the night could be due 
to the fact that previous hypoglycaemia can lower the threshold for the stimulation of 
counter regulatory hormones and thus the recognition of any symptoms of subsequent 
hypoglycaemia.  This study was not designed to evaluate the counter regulatory 
responses, though it has been demonstrated previously prior exercise resulting in 
hypoglycaemia can blunt counter regulatory responses to subsequent hypoglycaemia, 
decreasing the ability of individuals to recognise symptoms of hypoglycaemia and take 
action to prevent it (Sandoval et al., 2004; Jones et al., 1998).  It could be the case in 
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this study that prior episodes of hypoglycaemia associated with the exercise results in 
any LOPEH during the night being difficult to detect.   
 
From a patient perspective it is important to realise that the risk of LOPEH is elevated 
after both IHE and moderate intensity exercise and for those who tend to experience 
LOPEH, a low GI snack before bed, such as a wholegrain sandwich, banana or a mixed 
snack with fat and protein may be consumed to help reduce the risk of nocturnal 
hypoglycaemia (Shard et al., 2004).  It may also be important to warn patients that if 
they have experienced a previous episode of hypoglycaemia in relation to exercise they 
could be at risk of LOPEH and that the detection of this may be difficult.  It is also 
important to advise patients that after their meal following exercise where any reduction 
in insulin dose were made, they should check their blood glucose levels due to the risk 
of hyperglycaemia up to four hours after their meal.  This is particularly important due 
to the long term implications of repeated episodes of hyperglycaemia.   
 
5.2 Phase 2: Comparison of Blood Glucose Responses to a 30% v a 50% Post -
Exercise Fast Acting Insulin Reduction after IHE.  
 
Phase 1 of this research compared the blood glucose responses to moderate or IHE with 
a 30% post-exercise fast acting insulin reduction.  It was then decided to further 
decrease the insulin dose reduction to 50% following the IHE protocol.  The 50% 
insulin reduction strategy was thus compared to the 30% insulin reduction following a 
bout of IHE.  Results demonstrated that when all variables are reproduced: the intensity, 
timing and duration of exercise, the blood glucose responses to IHE were similar on two 
separate occasions.  Despite the individual variability in blood glucose responses, a 50% 
post exercise insulin dose reduction is no better for the prevention of LOPEH than a 
30% insulin dose reduction after IHE performed in the afternoon.  However a 50% post 
exercise insulin reduction caused a number of participants to have an episode of 
hyperglycaemia 2-4 hours post meal.    
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5.2.1 Blood Glucose Responses to Exercise 
 
This study found a mean reduction in blood glucose of 3.6 ± 2.3 mmol.l
-1
 for the 30% 
IHE and 3.4 ± 1.6 mmol.l
-1
 for the 50% IHE condition.  In both exercise conditions one 
participant experienced a hypoglycaemia episode at the end of exercise.  Post-hoc tests 
indicate that there was a significant difference in blood glucose concentration between 
the start and end of the exercise trials, regardless of condition.  This demonstrates that 
IHE of this nature can cause a significant reduction in blood glucose concentration.  The 
slightly higher blood glucose concentration during exercise under the 50% condition, 
albeit not significant could have been obtained at the cost of having a higher starting 
blood glucose concentration.            
 
Compared to this study, Iscoe and Riddell (2011) showed a larger reduction in blood 
glucose concentration of 5 ± 0.5 mmol.l
-1
 for 45 minutes of cycling IHE, whereas Guelfi 
et al (2005b) reported a reduction of 2.9 ± 0.8 mmol.l
-1
 with 30 minutes of cycling IHE.  
It could be that the duration and the composition of the IHE performed could explain in 
part the differences in the decline in blood glucose concentration between the studies.  
The largest decline in blood glucose concentrations was found in the study with the 
longest duration of exercise (45 minutes) and the longest duration of high intensity 
bouts (9, 15 seconds sprints at 100% WR peak) (Isoce and Riddell, 2011).  While Guelfi 
et al (2005b) demonstrated the smallest decline in blood glucose concnetrations for the 
shortest duration of exercise (30 minutes) and at a lower intensity (40% OV 2 peak with 
4 second sprints every 2 minutes) with considerably shorter sprint durations to that of 
Iscoe and Riddell, (2011).  Differences in blood glucose concentrations could also be 
due to the training status of the participants, with lower OV 2 max levels for participants 
in this study, in comparison to Iscoe and Riddell, (2011) and Guelfi et al (2005b).  
Despite some of these differences the same pattern of decline in blood glucose response 
has been demonstrated for IHE.   
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5.2.2 Blood Glucose Responses Post-Exercise 
 
Similarly, all blood glucose values after the meal, recorded by the CGM (Ipro2) are 
reported as interstitial blood glucose values.  Bonferroni post-hoc results revealed that 
there was no difference in blood glucose concentrations from 40 minutes until tea time, 
regardless of exercise condition.  Despite tests revealing no significant differences 
hypoglycaemia was still recorded in one patient under the 50% condition and two under 
the 30% condition.  As previously discussed in the results of Phase 1 of this research, 
hypoglycaemia at this time could be a result of the need for replenishment of muscle 
glycogen stores as a result of the exercise performed.     
 
From tea up to four hours interstitial blood glucose concentration  rises under both the 
30% and the 50% condition, with a greater peak at two and four hours under the 50% 
insulin reduction condition (average blood glucose increase for 50% IHE = 7.2 v. 4 
mmol.l
-1
 in 30% IHE).  It should be noted that despite the seemingly large rise in 
interstitial blood glucose concentrations there was no significant differences found 
between the two conditions.  Under the 50% insulin reduction, the percentage time 
spent above the ideal range was greater (50% IHE: 69 ± 26.6; 30% IHE: 61 ± 30.6 %).  
The greater peak in interstitial blood glucose concentration and the greater time spent 
above the ideal range in the 50% insulin reduction condition was expected due to the 
greater reduction in insulin, stimulating a more pronounced rise in blood glucose 
concentrations.  Previously higher plasma glucose concentrations with lower insulin 
doses have been attributed to lower concentrations of circulating insulin (Rabasa-Lhoret 
et al., 2001).  
 
The reduction in 50% insulin dose could perhaps have been too much since interstitial 
blood glucose concentrations appeared to be quite high, causing episodes of 
hyperglycaemia and one participant even recorded an interstitial blood glucose 
concentration of 22 mmol.l
-1
.  It could be the case for some individuals that too little 
insulin was taken in relation to food intake.  However, this is difficult to say as 
participants were not required to eat a standardised meal with similar carbohydrate 
content.  From a practical point of view avoiding high blood glucose concentrations 
after exercise is not only beneficial for improved glycaemic control but may also 
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prevent the occurrence of hypoglycaemia as individuals will be less likely to administer 
corrective insulin dose, which in a post-exercise insulin sensitive state could cause a 
rapid decline in blood glucose concentrations (Pierce, 1999).  For reasons previously 
stated in relation to Phase one of this research, it is important for patients to be aware of 
the risk of hyperglycaemia and the times where this is likely to occur.       
   
It is important to note the individual variation in responses as the increase in interstitial 
blood glucose concentration across both conditions for all participants ranged from 2.3-
14.9 mmol.l
-1
 from tea – four hours.  This variation in response could again attest to the 
high standard deviation values seen around two and four hours post-meal time.  As 
previously mentioned this in part could be due to different meal compositions 
(particularly carbohydrate amounts) that affect gastric emptying, pre-meal plasma 
insulin concentrations and the difference in the insulin absorption rates between 
participants.  It is most likely that the largest flaw in being able to detect the true impact 
of the intervention within this study was not standardising the post-exercise meal 
content for every individual.   
      
Interstitial blood glucose concentrations show a decline under both conditions from six 
hours until 10-12 hours post-meal.  Hypoglycaemia was evident in both conditions 
(30% IHE: 3 episodes; 50% IHE: 2 episodes) however the risk of hypoglycaemia under 
the 50% condition was only evident at 10 hours.  The time spent within the ideal range 
was greatest in the 30% insulin reduction condition; however again judging by the large 
standard deviations there was a large variation in the interstitial blood glucose responses 
between individuals.  Despite this, IHE in the afternoon with either a 30% or a 50% 
insulin reduction is still characterised by the risk of LOPEH.  It also appears that 
hypoglycaemia unawareness is a problem since three episodes went unrecognised 
overnight.  As previously discussed this could be due to the blunting of the counter 
regulatory response due to prior hypoglycaemia associated with the afternoon exercise 
as two out of the three individuals experienced hypoglycaemia in relation to the exercise 
(Sandoval et al., 2004).   
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Despite a 20% reduction in post-exercise, meal time insulin it has been observed that 
afternoon IHE puts participants at risk of delayed hypoglycaemia (Maran et al., 2010).   
As a result Maran et al (2010) suggests that IHE should be considered an undesirable 
form of exercise for individuals with type 1 diabetes.  In contrast it has been reported 
that IHE results in blood glucose values that are similar to remaining sedentary 
throughout most of the evening and the early night, and that the risk of LOPEH is not 
heightened by taking part in IHE (Iscoe and Riddell, 2011).  It was thought that the 
reason for the attenuation in blood glucose concentrations throughout the night was due 
to a 30g low GI snack given without bolus insulin at bedtime (Iscoe and Riddell, 2011).  
Considering the results of Iscoe and Riddell (2011) and that of Maran et al (2010) and 
this study, it may be questionable whether such a reduction in insulin dose is required, 
given that nocturnal glycaemia is similar to an evening following a sedentary day (Iscoe 
and Riddell, 2011).  In addition without such a reduction in insulin dose, this may help 
prevent unwanted hyperglycaemia.  However it should be noted that 27% of participants 
still experienced hypoglycaemia during the night after IHE in Iscoe and Riddell’s 
(2011) study, indicating that participants differ in their responses to exercise and advice 
that is suitable for one individual may not be suitable for another.   
 
This chapter has discussed and analysed the results from the empirical data collection of 
this study.  The following chapter will go on to conclude this work and provide 
application to patient practice.   
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Chapter 6  
Conclusions 
 
Increasing numbers of individuals with type 1 diabetes want to enjoy and take part in 
sport and exercise (Gallen, 2005).  However since exercise is one of the main causes of 
hypoglycaemia in individuals with type 1 diabetes, guidelines in order to prevent this 
are important.  Existing guidelines to minimise the risk of hypoglycaemia associated 
with exercise in those with type 1 diabetes, are often very general and few take into 
account that different advice is required for exercise of varying intensity and duration.   
At present, to knowledge there are still no evidence based recommendations for insulin 
and carbohydrate adjustments during IHE for individuals with type 1 diabetes.  This 
piece of research therefore came about through the realisation that diabetes 
professionals may not feel confident in advising patients to manage their diabetes in this 
context.  It was with this in mind that the overall aim of this research was to investigate 
the effects of a structured intervention for insulin and carbohydrate adjustment on blood 
glucose responses during and after IHE that replicates team and field based sports in 
individuals with type 1 diabetes.   
  
To this end the following research objectives aimed to: 
1. Identify and critically appraise current evidence detailing the impact of IHE on 
blood glucose concentrations in individuals with type 1 diabetes.  
2. Compare the effects of a 30% post exercise fast acting analogue insulin 
reduction on the blood glucose responses to a bout of IHE vs. continuous 
moderate intensity exercise in individuals with type 1 diabetes.  
3. To compare the blood glucose responses to a 30% vs. a 50% post exercise fast 
acting analogue insulin reduction after a bout of IHE in individuals with type 1 
diabetes.  
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This chapter will revisit the overall aim and specific research objectives outlines above.  
The findings are summarised and related to the research objectives.  Conclusions from 
this research are derived, limitations of this research are also highlighted, along with 
directions for future research.  
 
6.1 Summary of Findings and Conclusions 
 
Initially the literature review outlined in Chapter 2 revealed that there were only six 
studies (Iscoe and Riddell, 2011; Maran et al., 2010; Guelfi et al., 2007; Guelfi et al., 
2005a&b; Ford et al., 1999) available in the literature that had examined the blood 
glucose responses to IHE in individuals with type 1 diabetes.  Results of these studies 
were conflicting and thus advice for insulin and carbohydrate adjustments were not 
evidence based and had never been tested in practice.  For this reason the empirical 
research within this study has utilised a novel intervention for insulin and carbohydrate 
adjustment in relation to exercise.  In addition previous studies have used exercise 
modes and work to recovery ratios that were not representative of IHE (Iscoe and 
Riddell, 2011; Maran et al., 2010; Guelfi et al 2007; Guelfi et al 2005a&b; Ford et al., 
1999).  This study therefore used an original IHE protocol that took into consideration 
time spent in each separate activity pattern in team sports from time motion analysis 
studies (Spencer et al., 2005).   
 
Research objective two demonstrated that there was no difference between the decline 
in blood glucose concentrations for IHE or moderate intensity exercise performed in a 
post absorptive state in the afternoon, in individuals with type 1 diabetes.   This 
observation was unexpected due to the current research that suggests the high intensity 
sprint component associated with IHE helps to attenuate the decline in blood glucose 
concentrations that is frequently seen in moderate intensity exercise (Bussau et al., 2007 
& 2006; Guelfi et al., 2007a; Guelfi et al., 2005b).  It should be noted that the studies 
used varying exercise modes, intensities and the exercise was performed at different 
times of the day in comparison to this study.  It is therefore possible that the timing and 
the duration of exercise are important in modulating the blood glucose responses to 
exercise.  
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Despite a 30% reduction in post-exercise fast acting insulin at the following meal, there 
was no difference in the risk of developing LOPEH after IHE or moderate intensity 
exercise.  The 30% insulin dose reduction was insufficient to maintain blood glucose 
concentrations after IHE, therefore research objective three aimed to compare the 30% 
reduction to a further 50% insulin dose reduction following IHE.  Results demonstrated 
that blood glucose responses for the same bout of IHE in the afternoon were similar on 
two separate occasions.  Thus advice may be given to individuals based on the fact that 
the IHE protocol outlined in this study, performed in a post-absorptive state in the 
afternoon will cause a reduction in blood glucose concentrations of ~ 3.5mmol.l
-1
.  It is 
important to note, however, that there will be moderate variability in this response.  
Despite the individual variability in blood glucose responses evident in this study, a 
50% post-exercise insulin dose reduction is no better for the prevention of LOPEH than 
a 30% insulin dose reduction after IHE performed in the afternoon.  
 
General observations from this study suggests that there are two main high-risk periods 
for the development of hypoglycaemia associated with IHE or moderate intensity 
exercise performed in the late afternoon in a post-absorptive state.  The first of these 
occurs immediately following the cessation of exercise and the second occurs later on 
during the night and is potentially coincident with sleep.  These two high-risk periods 
have previously been demonstrated for moderate intensity exercise in the afternoon in 
adolescents with type 1 diabetes (McMahon et al., 2007).  In addition this study 
revealed that hypoglycaemia unawareness during the night was a potential problem and 
it was hypothesised that it could be due to inadequate counter regulatory hormone 
responses.  This however remains to be validated as these underlying mechanisms were 
not investigated in this study.   
 
Although the emphasis throughout this study has been on hypoglycaemia in relation to 
exercise since this is the most frequent worry in patients, it is worth noting that this 
study has indicated that there could be a problem of high blood glucose levels leading to 
hyperglycaemia, particularly up to 4 fours following the evening meal. This could 
potentially be due to the fact that the insulin reduction for the form of exercise in this 
study was too great.  Again the underlying mechanisms for this were not investigated in 
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this study.  It is however important to make patients aware that not only hypoglycaemia 
is a problem, but hyperglycaemia may also be a problem, particularly after the evening 
meal if an insulin reduction strategy is utilised.  
    
One of the biggest observations however was the variation in blood glucose responses 
between participants.  This indicates that individuals vary greatly in their responses to 
exercise and thus individual strategies to combat the risk of hypoglycaemia and 
hyperglycaemia may be required.        
 
6.2 Limitations 
 
Although this study has contributed to the understanding of the blood glucose responses 
to IHE in individuals with type 1 diabetes and the management strategies that may be 
required, a number of limitations must be acknowledged.  Firstly the findings of this 
research apply to a group of habitual exercisers with type 1 diabetes exercising under 
particular conditions.  These include exercise for 40 minutes at either a moderate 
intensity (50% OV 2 ) or IHE (cycles of 40% OV 2 for 5 minutes, 70% OV 2  for 3 
minutes, 125% OV 2 for 5 seconds).  Exercise was performed in a post-absorptive state 
in the late afternoon with 30% or 50% reductions in fast acting insulin doses post- 
exercise.  Therefore caution should be taken when applying these results to other 
individuals performing exercise of varying intensity and duration, at different times of 
the day and with different insulin and carbohydrate regimes.   
 
In addition the IHE protocol was performed in the laboratory and only provides the 
basis for the physiological stress of IHE and will not truly reflect the complex activity 
patterns performed in the field during team sport activities.   Furthermore most team 
sports last up to 80-90 minutes with a half time break which would allow the intake of 
carbohydrates and adjustments to insulin regimes.  This research only represents a 
proportion of a game within the field.  Caution should therefore be taken when applying 
these results to team sports.  
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It is also acknowledged that this study does not identify possible mechanisms for the 
blood glucose responses found here within this research.  Complex metabolic and 
physiological measures have not been measured during the study.  The purpose however 
for this was to ensure that the focus was on patient information and education.  The aim 
of this study was not to produce physiological or metabolic reasons for blood glucose 
responses, but to provide some patient information about what is likely to happen as a 
result of exercise at certain intensity, at a certain time of the day and with certain insulin 
and carbohydrate adjustments.  It was hoped that results would thus allow some 
application to patient practice.   
 
In addition, as mentioned in the Discussion, Chapter 5, the post-exercise meal was not 
standardised for every individual and it is acknowledged that this may have in part 
caused the large variations in the blood glucose responses seen particularly around tea-
four hours post.   As a result it may have impacted upon the true effect of the 
intervention, and future studies may want to standardise the amount and content of the 
meal post-exercise in order to take into account the effects of the GI of different 
carbohydrate types that affect gastric emptying rates.      
 
It is important to note that the lag time associated with the interstitial blood glucose 
reading with the CGM (noted in methods, Chapter 3B) can limit the accuracy of the 
CGM for predicting blood glucose levels.  This could have been particularly true 
straight after the post exercise insulin reduction and the meal in this study, as blood 
glucose concentrations would be changing so rapidly.  However the accuracy of these 
readings were improved through the calibrations that were taken by asking the 
participants to record their blood glucose at least four times a day using their SBGM.  
Despite this fore mentioned limitation, the CGM is still a useful tool for the prediction 
of blood glucose trends, particularly during periods where individuals do not regularly 
check their blood glucose, ie following meal times and during the night.      
 
It should also be acknowledged that the lack of statistical significance within the study 
could be due to the very small sample size and the large variation in the blood glucose 
responses to exercise.  Small sample sizes and the skewness of the data relating to the 
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number of hypoglycaemia episodes and time spent in the ideal range, made it 
impractical to carry out statistical analysis.  Caution should be taken thus with the 
percentage time in the ideal range results as this is a very robust measure due to the 
large variability between patients, making it very difficult to detect any differences.  
The small sample size is inevitable however with clinical trials that have a strict 
inclusion criteria and possess significant time commitments.  While the changes may 
not be statistically significant, results may be physiologically meaningful for the 
participants and information may be able to be provided on an individual basis 
regarding safe participation in IHE.     
 
 
6.3 Implications 
 
Assuming that some of the major limitations in this study: small sample size and lack of 
control over carbohydrate intake, are addressed in future research, there could be future 
implications for patient practice.   
 
Recommendations for individuals with type 1 diabetes wishing to take part in IHE are 
often conflicting and suggest similar management strategies for both continuous 
moderate intensity exercise and IHE (Birrer and Sedaghat, 2003; Pierce, 1999).  This 
recommendation is not supported by current research which demonstrates that there is a 
difference in the responses of blood glucose concentrations to moderate and IHE (Iscoe 
and Riddell, 2011; Maran et al., 2010; Guelfi et al., 2005b).  However within this 
research study it has been found that moderate and IHE result in similar blood glucose 
responses both during and after exercise, thus indicating a similar risk for the 
development of LOPEH and also hyperglycaemia.  This observation has never been 
discovered before and therefore the advice that IHE should be performed over moderate 
intensity exercise to minimise the risk of hypoglycaemia (Guelfi et al., 2005b) is an 
oversight and is not in agreement with results from this study.  Further research into the 
blood glucose responses to IHE utilising a CGM are required.  The use of a CGM aids 
in raising awareness and provides clinicians and those with type 1 diabetes detailed 
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information on glucose responses to exercise.  In particular it can highlight blood 
glucose responses overnight, which has been shown in this study to be a high risk time 
for the development of hypoglycaemia and also it can highlight the risk of 
hyperglycaemia immediately after the evening meal, where again participants may not 
be trained to check blood glucose levels.  The use of CGMs’ may facilitate insulin and 
carbohydrate adjustments in relation to exercise.     
 
Instead of reducing pre-exercise insulin doses before exercise, individuals could aim for 
a pre-exercise blood glucose level of 10 mmol.l
-1
.  This is higher than what was 
originally suggested in the intervention.  This research has shown for the same IHE 
performed on two different occasions the average blood glucose drop will be ~3.5 
mmol.l
-1
.  Therefore for IHE performed in the late afternoon in a post-absorptive state, 
advice may therefore be offered based on this knowledge .  Assuming this, if exercise 
commenced with blood glucose concentrations at 10mmol-
1
, then blood glucose would 
still remain within a safe range during and after the exercise bout.  There may however 
be variation in the responses between individuals and therefore caution should be taken 
when applying this advice to all those individuals with type 1 diabetes.     
 
In addition, individuals may require additional carbohydrate supplementation straight 
after exercise before the following meal.  The amount of carbohydrate taken could 
follow the advice previously given in the intervention prior to exercise and is outlined in 
Appendix 2.  This is based on advice that suggests that 10g of carbohydrate raises blood 
glucose concentrations by 2.5 mmol.l
-1
 (DAFNE, 2002).  However given the wide range 
of blood glucose responses and in particular the  inter and intra-variation in individuals 
responses to a particular amount of carbohydrate, it would be difficult to prescribe an 
exact quantity of carbohydrate to prevent hypoglycaemia in all individuals following 
IHE.        
 
In order to prevent LOPEH after exercise, Maran et al (2010) studied the response to 
IHE in the late afternoon with a following 20% fact acting insulin reduction.  Despite 
this intervention results reveal that IHE is characterized by the risk of LOPEH (Maran et 
al., 2010).  It would appear that a reduction of the insulin dose after exercise at the 
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following meal is insufficient to prevent LOPEH in individuals with type 1 diabetes.  In 
fact such an insulin dose reduction could lead to problems of hyperglycaemia, as found 
in this study.  Although not addressed, the mechanisms of hyperglycaemia could be 
presumed to be related to hepatic glucose output is increasing to a greater extent than 
muscle glucose uptake (Gallen, 2009).  However in order to understand the underlying 
mechanisms behind this, a more detailed analysis in terms of glucose kinetics and 
measurements related to counter-regulatory hormones is required, which is beyond the 
scope of this study.     
 
Various strategies have been employed to prevent LOPEH previously such as reducing 
the basal insulin dose and consuming extra carbohydrates prior to bed time (Iscoe and 
Riddell, 2011; Taplin et al., 2010).  However the reduction of the basal insulin dose is 
not ideal since this can affect the blood glucose concentrations for the following 24 
hours and there is the risk of developing hyperglycaemia (Taplin et al., 2010).  This 
strategy is thus not practical if exercise is performed on a frequent basis since regular 
hyperglycaemia can lead to long term complications such as diabetic retinopathy, 
neuropathy and cardiovascular disease (Pierce, 1999).  It also appears, as found in this 
study, that such a great reduction of insulin dose after exercise with the following meal 
can also cause high blood glucose levels in the following 2-4 hours after the evening 
meal, leading to hyperglycaemia, the opposite problem of hypoglycaemia.       
 
Additional carbohydrate intake before bed has been suggested to attenuate LOPEH after 
afternoon IHE.  A 30g carbohydrate drink following IHE appeared to reduce the risk of 
developing LOPEH in one study (Iscoe and Riddell, 2011).  The intervention in this 
current study suggested taking additional carbohydrate (10-20g) before bed if blood 
glucose concentrations were under 10 mmol.l
-1
.  Currently there are no standard 
guidelines in carbohydrate intake after exercise to decrease the risk of hypoglycaemia; 
however the consumption of complex carbohydrates mixed with fat and protein may 
help prevent blood glucose decline, by prolonging carbohydrate availability (Wilson et 
al., 2008).  As previously mentioned the amount of carbohydrate intake needed to 
maintain euglycaemia varies significantly between individuals because of numerous 
factors, including circulating insulin levels, energy expenditure, levels of glucose 
counter regulatory hormones, and training status.  Frequent blood glucose monitoring 
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(at least initially when trying new strategies) is strongly recommended so that various 
nutritional regimens can be tested.  
 
 
6.4 Directions for Future Research 
 
Future research efforts should attempt to adhere to rigorous methods whilst striving for 
larger sample sizes.  One strategy may include collaboration with other health care 
providers to gain access to additional patients.  In addition, in order to allow results to 
be applicable to all complicated free individuals with type 1 diabetes greater efforts 
should be made to recruit poorly controlled individuals.  It is often the individuals who 
are adherent to exercise and have well controlled type 1 diabetes that will choose to 
participate in a study.  It would be interesting to investigate the impact of this 
intervention on a group of naïve exercisers with HbA1c levels >10 %.    
 
In relation to intermittent exercise that is specific to team sports, future research may 
want to consider whether different work to recovery ratios would elicit a different blood 
glucose response.  The effect of a full game duration could be investigated and the 
blood glucose responses to an actual field game remains to be determined.  This would 
thus bring in additional factors such as half time breaks and the additional stress 
response to a competitive game situation.   
 
In relation to the intervention described in this research, future work should consider the 
impact of increasing the starting blood glucose concentrations prior to exercise and the 
addition of extra carbohydrate administration at the end of exercise prior to the 
following meal.  In addition more research is required in order to confirm if a reduction 
in insulin dose post-exercise is required in order to preserve blood glucose 
concentrations after IHE.  
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Finally gender differences were also not accounted for within this research, partly due to 
the fact that there were not enough participants to allow a meaningful statistical 
comparison.  This leaves the question of whether a gender difference exists in the 
responses to IHE and would different management strategies be required?  Furthermore, 
specifically for females would the phase of the menstrual cycle have an impact on the 
results?  Clearly further research of this kind is warranted for the development of more 
detailed evidence based guidelines for those with type 1 diabetes wishing to take part in 
IHE.  
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Interface - 
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Database - 
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"HYPERGLYCEMIA" OR DE 
"GLUCOSE"  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Basic Search  
Database - 
SPORTDiscus 
3644  
S4  S1 OR S2 OR S3  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Basic Search  
Database - 
SPORTDiscus 
132706  
S3  
intermittent high intensity 
exercise*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Basic Search  
Database - 
SPORTDiscus 
102  
S2  team* and sport*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Basic Search  
Database - 
SPORTDiscus 
131895  
S1  intermittent exercis*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Basic Search  
Database - 
SPORTDiscus 
855  
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CINAHL 
 
Thursday, June 28, 2012 11:59:33 AM  
 
#  Query  Limiters/Expanders  Last Run Via  Results  
S8  S6 and S7  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
18  
S7  
(MH "Blood Glucose") OR 
"blood glucose" OR (MH 
"Blood Glucose Self-
Monitoring")  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
15927  
S6  S1 and S5  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
10  
S5  S2 or S3 or S4  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
1829  
S4  team* and sport*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
1599  
S3  
intermittent high intensity 
exercis*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
19  
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CINAHL Plus with 
Full Text  
S2  intermittent exercis*  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
242  
S1  
(MH "Diabetes Mellitus, 
Insulin-Dependent")  
Search modes - 
Boolean/Phrase  
Interface - 
EBSCOhost 
Search Screen - 
Advanced Search  
Database - 
CINAHL Plus with 
Full Text  
8826  
 
Cochrane Library 
ID Search Hits Edit Delete 
#1 MeSH descriptor Diabetes Mellitus, Type 1 explode all trees 2810 edit delete 
#2 (intermittent exercis*):ti,ab,kw 804 edit delete 
#3 (team* and sport*):kw 0 edit delete 
#4 (intermittent high intensity exercis*):ti,ab,kw 82 edit delete 
#5 
(intermittent exercis*) or (intermittent high intensity 
exercis*):ti 
1072 edit delete 
#6 (#1 AND #5) 3 edit delete 
#7 blood glucose  16009 edit delete 
#8 (#6 AND #7) 6 edit delete 
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APPENDIX 2 
INTERVENTION FOR INSULIN AND CARBOHYDRATE 
ADJUSTMENT IN RELATION TO EXERCISE 
 
Before exercise 
Bolus/meal insulin 
 If exercising within 2 hours of eating a meal, reduce the bolus/meal dose by 50% 
 
Blood glucose 
 Aim for blood glucose at 8 mmol immediately before exercise 
 If blood glucose over 12mmol,  
- check for ketones 
- take a correction dose 
 If blood glucose over 17mmol do not exercise 
 If blood glucose under 8 mmol have the following carbohydrate (CHO): 
 
Blood glucose prior to exercise Amount of CHO (gm) 
 
Under 4 30 
4 – 6 20 
6 – 8 10 
8 or over 0 
 
After exercise 
Bolus/meal insulin 
 If eating within 2 hours of exercise, reduce the bolus/meal dose by 30% 
 After 2 hours return to usual dose 
Long acting insulin  
 Take usual Lantus or Levemir dose 
Blood glucose 
 If blood glucose at 8 mmol or under before bed have 10-30 grammes of CHO 
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APPENDIX 3 
PARTICIPANT INVITES/INFORMATION SHEET 
 
 
 
 
EDINBURGH NAPIER UNIVERSITY 
Faculty of Health, Life and Social Sciences Research Ethics and Governance 
Committee  
 
Participant Information Sheet 
 
My name is Lorraine Steel and I am an MSc Research student from the Faculty of 
Health, Life and Social Sciences at Napier University in Edinburgh.  As part of my 
postgraduate degree course, I am undertaking a research project for my Masters 
dissertation.   
 
The title of my project is: Blood Glucose Responses to Intermittent High Intensity 
Exercise in Individuals with Type 1 Diabetes: A Trial of a Structured Intervention 
for Insulin and Carbohydrate Adjustment 
Background: 
At present existing guidelines to minimize the risk of hypoglycaemia associated with 
exercise in type 1 diabetic patients are often general and fail to take into account 
exercise of different types, durations and intensities.  Specifically there are no 
guidelines for individuals wanting to participate in Intermittent High Intensity Exercise.  
This type of exercise involves short bouts of intense activity, interspersed with longer 
periods of lower intensity activity.  This type of exercise is typical of many team based 
sports such as football, rugby and hockey. 
 
The aim of the proposed research is to investigate the effects of a structured 
intervention for insulin and carbohydrate adjustment on blood glucose responses during 
and after intermittent exercise that replicates team and field based sports in individuals 
with type 1 diabetes.   
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It is hoped that the findings will add to the current research on Intermittent Exercise and 
will lead on to developing appropriate insulin dose reductions and carbohydrate 
supplementation for type 1 diabetics to allow safe participation in intermittent activities. 
 
What is required of you:  
 
1. Prior to inclusion in this study, you will be required to undergo a medical 
screening by completion of a pre-test questionnaire in order to ensure that 
you are suitable for this study and that participation will not put you at any 
risk.  Your GP will be informed that you are participating in this research.  
 
2. Testing will take place over 4 separate days with 1 week between each 
testing session.  All sessions will take place at the School of Life Sciences 
(Sport and Exercise Science, Napier University, Colinton Road, Edinburgh).  
Each session will involve exercise so please come in comfortable clothing 
and footwear. 
 
3. On day 1 you will be asked to attend the lab for a familiarization session 
during which anthropometric measurements will be taken (height, weight),  
and blood pressure will be recorded. OV 2 max is the maximal capacity of 
your body to transport and use oxygen during exercise and it reflects your 
physical fitness.   Your OV 2 max will be estimated using a sub-maximal 
incremental walking protocol on the treadmill.  This will require you to be 
being fitted with a heart rate monitor and a face mask for breath by breath 
gas analysis.  This should take no longer than 1 hour.   
 
4. On day 2 you will be asked to perform the moderate intensity protocol in the 
physiology lab.  Before exercise you will be fitted with the Guardian RT 
Medtronic blood glucose monitoring device and given instructions on its use.  
You will also be taken through the procedures for recording food intake, 
insulin dosage and physical activity levels that will be required of you 
throughout the study.  The exercise will involve continuous running at 50% 
OV 2  max for 40 minutes.  Your OV 2  max will be determined from your 
initial OV 2  max test on day 1.  During this time heart rate, rates of 
perceived exertion and blood glucose will be recorded.  
 
5. On day 3 you will be asked to perform the intermittent protocol in the 
physiology lab.  Before exercise you will be fitted with the Guardian RT 
Medtronic blood glucose monitoring device and given instructions on its use.  
You will again be taken through the procedures for recording food intake, 
insulin dosage and physical activity levels that will be required of you 
throughout the study.  The exercise will take 40 minutes and will involve 
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you performing cycles of walking at 40% 2OV

max for 5 minutes, jogging at 
60% 2OV

max for 3 minutes and sprinting at 125% 2OV

max for 5 seconds.  
During this time heart rate, rates of perceived exertion and blood glucose 
will be recorded.  It should be noted that this protocol will require you to run 
at fast speeds on the treadmill during the sprinting period.   
 
6. On day 4 you will be asked to repeat the intermittent protocol outlined 
above. This will take place approximately 1 month after the last session.    
 
7. Prior to all exercise sessions you will be asked to follow your usual insulin 
regime and ensure that it is the same for both trials. You will be given some 
advice based on an intervention for insulin and carbohydrate 
supplementation.  In addition your food intake should be similar for both 
trials and caffeine, alcohol and structured exercise should be avoided 48 
hours before testing.  This will be explained in more detail to you when you 
arrive on Day 1 of testing.      
 
Criteria for Inclusion: 
In order to participate in this study you must be between the age of 20-50, type 1 
diabetic of at least 2 years, have an HbA1c of under 10%, are physically active for 20 
minutes or more at least twice a week and undertake a mixture of competitive or 
recreational sports.  All participants should use a basal bolus insulin regime with 
analogue insulin and will be experienced with carbohydrate counting and insulin dose 
adjustments. 
You will not be eligible for this study if you have any of the following:  
diagnosed peripheral vascular disease, orthopaedic problems, diagnosed heart disease, 
proliferative retinopathy, peripheral neuropathy, hypoglycaemic unawareness. 
 
What are the Risks? 
 
The risks involved are minimal but may involve potential fatigue due to the exercise 
protocols.  Wearing of the Guardian RT monitor may be inconvenient however will 
provide valuable data on your blood glucose responses during and after exercise.  
Should you experience hypoglycaemia or any other complications during any of the 
exercise sessions a trained diabetic nurse will be present at all times.  
You will be free to withdraw from the study at any stage, you would not have to give a 
reason, and it will not affect your treatment.  
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All data will be anonymous and your name will be replaced with a participant number 
or a pseudonym, and it will not be possible for you to be identified in any reporting of 
the data gathered. Any data collected will be kept in a secure place to which only myself 
and my academic supervisor has access. This will be kept until the end of the research 
process.  
 
The results may be published in a journal or presented at a conference.  It will also be 
possible for you to obtain an explanation of the results in written or verbal form to help 
with your understanding of your diabetes and exercise.   
 
If you have any further questions then please do not hesitate to contact me.  If you 
would like to participate in this study then please see the attached consent form. 
 
Thank you for your time 
 
Lorraine Steel 
 
Email: **** 
 
 
 
 
 
 
 
 
 
 
 
 
 
138 
 
 
APPENDIX 4 
PARTICIPANT CONSENT FORM 
 
 
Edinburgh Napier University 
Faculty of Health, Life and Social Sciences Research Ethics and Governance 
Committee 
 
Consent Form 
 
Blood Glucose Responses to Intermittent High Intensity Exercise in Individuals 
with Type 1 Diabetes: A Trial of a Structured Intervention for Insulin and 
Carbohydrate Adjustment 
 
I have read and understood the information sheet and this consent form.  I have had an 
opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in this study. 
 
I understand that I have the right to withdraw from this study at any stage without 
giving any reason. 
 
I agree to participate in this study. 
 
 
 
Name of participant:  _____________________________________ 
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Signature of participant: _____________________________________ 
 
 
 
Signature of researcher: _____________________________________ 
 
 
 
Date:   _________________ 
 
 
 
Contact details of the researcher: 
 
Name of researcher: Lorraine Steel, MSc Diabetes and Exercise Student 
 
Address:  ***** 
 
Email / Telephone: ***** / ***** 
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APPENDIX 5 
HEALTH AND ACTIVITY QUESTIONAIRE 
 
School of Life Science 
Edinburgh Napier University 
 
Questionnaire to be administered at visit 1 to establish routine management of 
diabetes when exercising.                                                                         
 
Your Type of Exercise or Activities 
 
1. How often do you exercise per week?  Please circle. 
 
Once a week 2 –3 times a week 4 – 6 times a week Daily 
 
2. What type of exercise do you do? (please specify, include more than one if 
necessary) 
 
 
3. Approximately how long for?  
 
20mins     30mins 45mins       1 hour      2hours   Longer  
 
4. What is the usual time of the day? 
 
Before breakfast   Morning Afternoon Before Tea Evening 
 
5. Why do you exercise?   
 
To lose weight     To tone up    To get fit   To feel better  
To improve your blood sugars    Other (please specify) 
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6. Would you describe your exercise as (please tick): 
a) Short and Sharp (up to 60 minutes) e.g. exercise or dance class, 
treadmill, swimming. 
b) Long and Leisurely e.g. walking, golf. 
c) Prolonged and Enduring (over 1 hour) e.g. football, tennis, rugby, 
distance running. 
 
Your Insulin 
 
1. What types of insulin do you take? 
 at meal times 
 at bed time 
 
 
2. What are your usual doses? 
 
Breakfast  Lunch  Tea  Bed  Other times 
 
 
3. Do you adjust your insulin doses when exercising? If yes, what do you do? 
 
 
4. What do you do with your injection sites when exercising?  
 
 
Your diet 
 
1. How do you manage your diet before or after exercising?  
 
 
2. Do you eat or drink anything immediately before? If yes, what? 
 
 
 
Problems you may have 
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1. Does exercise cause any problems with your blood sugars? If yes, what? 
 
 
 
2. How do you try to overcome any problems? 
 
 
 
3. Do you ever have hypo’s either during or after exercise?  
 
Never       Less than half the time                  Half the time or more             Every time 
 
 
4. Have you ever had a severe hypo where you needed assistance from someone? 
 
Never       Once     Twice     More than twice 
 
 
5. Do you ever have night time hypo’s after exercise? 
 
Never       Less than half the time                  Half the time or more             Every time 
 
Advice you have been given 
 
5. Is there any information we could have given you that would have helped? 
(please tick) 
Insulin adjustment 
Carbohydrate adjustment 
Hypo management 
Other please specify 
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School of Life Sciences 
Napier University, Edinburgh 
 
ASSESSMENT IN THE EXERCISE PHYSIOLOGY LABORATORY 
PRE-TEST QUESTIONNAIRE 
   
ALL THE INFORMATION RELATING TO THESE PROCEDURES IS 
CONFIDENTIAL 
 
 
 
NAME 
……………………………………………………………………………………………
… 
 
DATE OF BIRTH  ………………………………..     AGE …………………     B.P     
 
……………..…………mm Hg 
 
As you are to be a subject in this laboratory, it is necessary for you to complete the 
following questionnaire.   
Please circle the appropriate statement. 
How would you describe your present level of activity? 
Sedentary /moderately active /active /highly active 
 
How would you describe your present fitness level? 
very unfit /moderately fit /trained /highly trained 
 
How often do you participate in exercise of a maximal nature?   
Never /sometimes /often 
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How would you consider your present body weight? 
Underweight /ideal weight /slightly overweight /very overweight 
 
 
Are you a regular smoker?  Yes/No – if yes number per day……… 
Are you an occasional smoker? Yes/No – if yes average per week……. 
Are you a previous smoker? Yes/No – if  yes how long since stopping 
          ..… yrs
  
 
Do you drink alcoholic drinks?    Yes/No 
 
If yes do you:  have the occasional drink?  Yes/No 
   have a drink every day?  Yes/No 
   
 
Have you had to consult your doctor within the last 3 months? Yes/No – if yes give 
details  
 
……………………………………………………………………………………………
…… 
 
 
Are you currently taking any form of medication?   Yes/No – if yes give 
details 
 
……………………………………………………………………………………………
…… 
 
 
Do you suffer, or have ever suffered, from        
 
Asthma?  Yes/No 
       Diabetes?  Yes/No 
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       Bronchitis?  Yes/No 
       Epilepsy?  Yes/No 
      any form of Heart complaint?  Yes/No 
 
 
Is there a history of heart disease in your family?   Yes/No – if yes give 
details 
 
……………………………………………………………………………………………
…… 
 
Do you currently have any form of muscle or joint injury?  Yes/No – if yes give 
details 
 
……………………………………………………………………………………………
… 
 
 
Have you had any cause to suspend normal activity in the last two weeks? 
Yes/No – if yes give details 
 
……………………………………………………………………………………………
…… 
 
 
Have you any allergies to plasters, Micropore tape, skin electrodes, latex gloves 
         Yes/No – if yes give 
details 
 
……………………………………………………………………………………………
…… 
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To the best of your knowledge is there any other reasons that may prevent you from 
successfully completing the tasks that have been explained to you? 
 
Yes/No – if yes give details 
     
 
……………………………………………………………………………………………
…… 
 
 
Have you donated blood in the last week?   Yes/No 
 
 
Signature of subject …………………………………………                .  Date  
 
Name of Academic Investigator/Project 
Officer…………………………………………………… 
 
Signature of  Academic Investigator/Project Officer 
………………………………………………. 
Please supply the name, address and telephone number of an emergency contact:  
(please print) 
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APPENDIX 6 
EXAMPLE OV 2 MAX CALCULATION 
 
 
Workload VO2 HR 
 
 
1 11.1 86 
 
 
2 15.1 101 
 
 
3 19.7 115 
 
 
4 24.6 133 
 
 
5 31.3 147 
 
 
6 35.1 164 
 
     Age Predicted HR max = 
196bpm 
  
     VO2 
max     
   196 = 3.128 x + 
52.95 
   143.05 = 3.128 x 
   x = 
45.7   
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Target VO2 = desired vo2 x vo2 
    40% 
 
50% 
 
70% 
 
125% 
0.40 x 45.7 
 
0.50 x 45.7 
 
0.70 x 
45.7 
 
1.25 x 
45.7 
18.28 
 
22.85 
 
31.99 
 
57.13 
 
Treadmill Speed for 40% 
  
Treadmill Speed for 50%  
18.28 = 3.5 + (0.2 s) + ( 0.9 s) x 0.001 
 
22.85 = 3.5 + (0.2 s) + (0.9 s) x 
0.001 
14.78 = 0.2009 s 
   
19.35 = 0.2009 s  
 s = 73.569 m. min 
   
s = 96.32 m.min 
 s = 4.4 k/h on treadmill  
  
s = 5.8 k/h on treadmill  
 
 
Treadmill Speed for 70% 
  
Treadmill Seed for 125% 
31.99 = 3.5 +(0.2 s ) + (0.9 s) x 0.001 
 
57.13 = 3.5 + (0.2 s) + (0.9 s) x 
0.001 
xcxxbv28.49 = 0.2009 s 
   
53.63 = 0.2009 s 
 s = 141.81 m.min 
   
s = 266.94 m.min 
 s= 8.5 k/h on treadmill  
  
s = 16 k/h on treadmill  
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APPENDIX 7 
PARTICIPANT MONITORING DIARY 
DAILY MONITORING DIARY     
Name:                   Date:  
 Breakfast Morning Lunch Afternoon Evening Meal Evening Bed During night 
Total CHO eaten 
(g) 
        
Extra CHO before 
Exercise 
 
Extra CHO during 
Exercise 
 
Extra CHO after 
exercise 
        
Blood glucose 
B=before 
D=during 
A=after 
*if not exercising 
record reading in 
before (B) section 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
Insulin taken         
Usual insulin dose         
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Exercise: 
 
How long for? 
 
 
 
What did you do? 
 
 
 
 
 
 
       
Hypo’s 
Tick appropriate box 
if experience and fill 
details in hypo diary 
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APPENDIX 8 
PARTICIPANT HYPOGLYCAEMIA DIARY 
 
Hypoglycaemic Episodes 
Please record all hypo’s related to exercise. 
Please rate as mild or severe i.e. mild = you can treat it yourself and severe = you need 
help from someone else. 
Date/ 
Time 
Mild 
or 
severe 
During 
exercise? 
Within 2 
hours of 
exercise? 
Over 2 
hours 
after 
exercise? 
During 
the 
night? 
Blood 
glucose 
(using 
meter) 
Symptoms 
you had 
Treatment 
(please 
circle) 
If other 
please 
specify 
  
Mild / 
Severe 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / 
No 
 
Yes / 
No 
 
 
mmol/l 
 
 
 
 
 
Dextrosol/ 
Lucozade/ 
Chocolate 
Hypostop 
/ 
Glucostop 
Glucagon 
Other: 
 
 
 
 
 
